LPBI Group News

8/13/2019

Agenda for SKYPE on 8/13, 2019 at 11AM EST – ALL FIT MEMBERS – Attendance is a MUST

 

Part A: Scientist Unit – FIT Members provide updates

• Dr. Williams

1. Genomics Volume 2, Part 7 & Part 8 Updates
2. WordPress.com – removal of Ads from a Scientific Journal on a Business account
3. Ongoing article publishing and article updates

• Professor Feldman 

1. Genomics Volume 2, Part 5: Evolution and Genomics – NGS 
2. Editorials for Genomics Volume 2
3. Interview with Gail – last week in Auagust

• Dr. Dror Nir 

1. Genomics Volume 2, Part 3: AI, Section 3.5 ML Algorithms in Medicine

• Dr. Saha and Dr. Irina Robu

1. Please make list of all your articles in the Journal SINCE 6/11/2019 – Update for https://pharmaceuticalintelligence.com/2019-vista/fit-members-who-works-on-what/
2. Any comments

Part B: Business Unit

• Rick – Latest on

1. IB Briefing to the Team
2. Lessons from Section #13
3. Vision on Business Development
4. Questions to the Board & Aviva
5. List of Accomplishments since 6/11/2019 – Update for https://pharmaceuticalintelligence.com/2019-vista/fit-members-who-works-on-what/

• Gail – Latest on

1. Implications of IB Briefing to the Team on Marketing Communication role
2. Lessons from Section #13
3. Vision on Marketing Communication
4. Questions to the Board & Aviva
5. List of Accomplishments since 6/11/2019 – Update for https://pharmaceuticalintelligence.com/2019-vista/fit-members-who-works-on-what/

• Amnon – Latest on

1. Implications of IB Briefing to the Team on Strategy
2. Lessons from Section #13
3. Vision on Strategy
4. Questions to the Board & Aviva
5. List of Accomplishments since 6/11/2019 – Update for https://pharmaceuticalintelligence.com/2019-vista/fit-members-who-works-on-what/

Part C: Board Members and Aviva  

 ALL FIT MEMBERS – PLEASE STUDY and be ready to discuss your own inputs and comment on all other contents related to PRICING as presented in the LINK, below

All Inputs in Consideration for Pricing LPBI Group’s IP Three Classes of Assets 

https://pharmaceuticalintelligence.com/2019/08/12/all-inputs-in-consideration-of-pricing-lpbi-groups-ip-three-classes-of-assets/

7/31/2019

 

7/28/2019

The Origin of Cancer and Carcinogenesis: New conceptual paradigm by @BjoernBruecher et al – Three Articles endorse by @AVIVA1950 @pharma_BI, Editors of

• Cancer Biology & Genomics for Disease Diagnosis.

http://www.amazon.com/dp/B013RVYR2K

 

• Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery

http://www.amazon.com/dp/B071VQ6YYK

 

Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancer

https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-019-1163-7

 

Epistemology of the origin of cancer: a new paradigm

https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-331

 

Disruption of homeostasis-induced signaling and crosstalk in the carcinogenesis paradigm “Epistemology of the origin of cancer”

https://www.4open-sciences.org/component/toc/?task=topic&id=1080

 

7/28/2019

Vast #IntellectualProperty #Portfolio in #LifeSciences, #Medicine, #Scientific #Publishing and #Media #ExecutiveSummary (link: https://pharmaceuticalintelligence.com/2019-vista/executive-summary/) pharmaceuticalintelligence.com/2019-vista/exe… via @pharma_BI  

@AVIVA1950

7/23/2019

• Our 2nd ALL FIT MEMBER Skype will take place on Tuesday, August 13, 2019 at 11AM EST – Agenda will be shared before the Skype

• It is a MUST attend once in two month Session during the Exit phase announced on 2/6/2019.
• Each ACTIVE FIT Member will present their contributions to our Venture since June 11, 2019
• LAST CALL for Contributions to Genomics Volume Two – Part 7 and Part 8
• Dr. Dror Nir works on 3.5 – ML Algorithms in Medicine; Dr. Williams works on Part 7&8 and Editorials; Prof. Feldman works on Part 5 and Editorials

https://pharmaceuticalintelligence.com/biomed-e-books/genomics-orientations-for-personalized-medicine/volume-two-genomics-methodologies-ngs-bioinformatics-simulations-and-the-genome-ontology/

• ALL posts written after 6/11/2019 on AI in Medicine — ARE in Genomics Volume 2 – check to see Your NAME – e-mail me if I missed one – chach all Parts !!
• ALL Scientists: Continue to Submit Posts for Part 7 & Part & and Part 3: AI in Medicine – All goes into this Volume – OUR LAST BOOK !!!!!!!!

 

• Executive Summary – Updated

  https://pharmaceuticalintelligence.com/2019-vista/executive-summary/

   

• Founder’s Vision

https://pharmaceuticalintelligence.com/vision/

 

7/19/2019

We will cover in REAL TIME these most prestigious events in the second half of 2019

 

• MinneBOS 2019, Field Guide to Data Science & Emerging Tech in the Boston Community, August 22, 2019, 8AM to 5PM at Boston University Questrom School of Business, 595 Commonwealth Avenue, Boston, MAhttps://pharmaceuticalintelligence.com/2019/07/31/minnebos-2019-field-guide-to-data-science-emerging-tech-in-the-boston-community-august-22-2019-8am-to-5pm-at-boston-university-questrom-school-of-business-595-commonwealth-avenue-boston/

 

• Charles River Laboratories – World Congress, Delivering Therapies to the Clinic Faster, September 23 – 24, 2019, Cambridge, MA

https://pharmaceuticalintelligence.com/2019/07/19/charles-river-laboratories-world-congress-delivering-therapies-to-the-clinic-faster-september-23-24-2019-cambridge-ma/

 

• 2019 Warren Alpert Foundation Award Ceremony and Acceptance Lectures by Awardees, October 3, 2019, Harvard Medical School, Boston, MAAward goes to Four Scientists for Seminal DIscoveries in OptoGenetics – Illuminating the Human Brain

https://pharmaceuticalintelligence.com/2019/07/18/2019-warren-alpert-foundation-award-goes-to-four-scientists-for-seminal-discoveries-in-optogenetics-illuminating-the-human-brain/

 

• 15th Annual Personalized Medicine Conference at Harvard Medical School – THE PARADIGM EVOLVES, November 13 – 14, 2019 • Harvard Medical School, Boston, MA

https://pharmaceuticalintelligence.com/2019/07/19/15th-annual-personalized-medicine-conference-at-harvard-medical-school-the-paradigm-evolves-november-13-14-2019-%e2%80%a2-harvard-medical-school-boston-ma/

 

• The New England Venture Summit being held December 4^th 2019 at the Hilton in Boston Dedham

https://pharmaceuticalintelligence.com/2019/07/23/2019-new-england-venture-summit-december-4th-2019-at-the-hilton-in-boston-dedham-ma-hosted-by-youngstartup-nevs/

 

6/16/2019

eProceeding 2019 Koch Institute Symposium – 18th Annual Cancer Research Symposium – Machine Learning and Cancer, June 14, 2019, 8:00 AM-5:00 PM ET MIT Kresge Auditorium, 48 Massachusetts Ave, Cambridge, MA

https://pharmaceuticalintelligence.com/2019/03/12/2019-koch-institute-symposium-machine-learning-and-cancer-june-14-2019-800-am-500-pmet-mit-kresge-auditorium-48-massachusetts-ave-cambridge-ma/

 

Tweets, Pictures and Retweets at 18th Annual Cancer Research Symposium – Machine Learning and Cancer, June 14, 2019, MIT by @pharma_BI and @AVIVA1950 for #KIsymposium PharmaceuticalIntelligence.com and Social Media

https://pharmaceuticalintelligence.com/2019/06/16/tweets-pictures-and-retweets-at-18th-annual-cancer-research-symposium-machine-learning-and-cancer-june-14-2019-mit-by-pharma_bi-and-aviva1950-for-kisymposium-pharmaceuticalintelligenc/

 

6/15/2019

6/15/2019

Thanks to Gail Thornton for arranging the Audio Podcast: On Air Now – 3D BioPrinting

Medical 3D BioPrinting – The Revolution in Medicine

Technologies for Patient-centered Medicine:

https://www.amazon.com/dp/B078QVDV2W

BioPrinting 2019 FINAL

BioPrinting 2019 FINAL

From: Partners in Health and Biz Radio Show

https://www.spreaker.com/user/pihandbiz/bioprinting-2019-final

 

6/14/2019

Gail wrote on 6/10/2019

• The audio podcast on the 3D-Bioprinting e-book will air this Saturday, June 15 @10am.  I will send you the link once I receive it from Partners in Health & Biz. 

And then we can write a short article and post it to the LPBI Group online journal.

 

6/10/2019

WHAT ARE LPBI Group’s NEEDS in June 2019

Aviva’s BOLD VISION on June 11, 2019

 

Task 1:   Artificial Intelligence in Medicine

– Weekly engagement

https://www.aiin.healthcare

 

Majority of healthcare organizations are testing out AI

June 05, 2019 | Amy Baxter | Connected Care

https://www.aiin.healthcare/topics/connected-

care/majority-healthcare-organizations-are-

testing-out-ai?utm_source=newsletter&utm_medium=cvb_news

 

Task 2:   Promotion of BioMed e-Series to Med Schools

– Monthly engagement

 

Task 3:   Going DIRECT for finding an M&A partner

– Quarterly engagement

 

Team Members’ Tasks Assignment

https://pharmaceuticalintelligence.com/2019-vista/what-are-lpbi-groups-needs-in-june-2019-avivas-bold-vision-on-june-11-2019/

 

6/10/2019

Books in use at US Medical Schools:

6/2019 – Susan B. Klein, PhD, Department of Physics, Indiana University, Bloomington

(another Berkeley alum) will be using for her forthcoming book on Radiation Biology, World Scientific Press, 2023, articles from the following three LPBI Group’s BioMed e-Series:

• Cardiovascular Diseases, Volume Three: Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics.

On Amazon.com since 11/29/2015

http://www.amazon.com/dp/B018PNHJ84

•  Volume 1: Genomics Orientations for Personalized Medicine. On Amazon.com since 11/23/2015

http://www.amazon.com/dp/B018DHBUO6

• Volume 1: Cancer Biology & Genomics for Disease Diagnosis. On Amazon.com since 8/11/2015

http://www.amazon.com/dp/B013RVYR2K

• Volume 2: Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery (Series C Book 2). On Amazon.com since 5/18/2017

http://www.amazon.com/dp/B071VQ6YYK

• 250 Medical Schools in the US
• Europe

In 2019, Class II, e-Books are in Use in Medical Schools in the State of Pennsylvania for curriculum development:

Series A: Volume 3 – Epigenetics, Genetics and Genomics [Jefferson Medical School, Philadelphia]

Series B: Volume 1 –  Genomics & Personalized Medicine [Temple University, Philadelphia]

Series C: Volume 1,2 – Cancer [Temple University, Philadelphia]

Series E: Volume 1 – Voices of Patients  [Jefferson Medical School, Philadelphia]

Case Western Medical School – need to follow up on a contact from the Conference that I covered at Harvard Law School on Genomics and Ethics on 5/17/2019.

 

@PharmaceuticalIntelligence.com Journal: Article Publication by LPBI Group’s FIT Members, January 2019 – June 2019

Reporter: Aviva Lev-Ari, PhD, RN

Curator’s Name	1/1/2019 – 6/30/2019	7/1/2019 – 12/31/2019
Dr. Sudipta Saha	20
Dr. Stephen J. Williams	37
Dr. Irina Robu	19
Dr. Dror Nir	4
Gail S. Thornton	7
Amnon Denzig	1
Rick Mandhal	1
Dr. Aviva Lev-Ari	94 [51.37%]
Total	183

 

1/22/2019	e-Readers	# Articles	Scientific Comments	Research Categories
LPBI Group	1,563,240	5,469	7,308	666
Aviva Lev-Ari, PhD, RN	393,545	3,245

 

5/29/2019

From: Harvard Medical School <pgme@hms.harvard.edu>

Reply-To: <pgme@hms.harvard.edu>

Date: Wednesday, May 29, 2019 at 1:16 PM

To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: Registration Pending Approval – Media & Medicine: How to Tell Stories That Make A Difference (Media & Med) 2020

Wednesday, May 29, 2019

Dear Aviva Lev-Ari,

Thank you for submitting your application for the Media & Medicine: How to Tell Stories That Make A Difference (Media & Med) 2020. Your application has been received and is under review. You will be notified of your application status within four weeks of submission.

Please note that only completed applications will be reviewed  for admission.

Click here to view your application details.
You will be asked to enter your confirmation number: DVNQ382RYR4

Please add pgme@hms.harvard.edu to your safe senders or contacts list to ensure you receive updates on your application and program announcements. Do not hesitate to contact us if you have any questions.

Thank you for your application to Media & Med Program.

Sincerely,

The Admissions Team
Postgraduate Medical Education
Harvard Medical School

 

5/28/2019

Most recent five articles on Schizophrenia in pharmaceuticalintelligence.com

• Molecular basis for schizophrenia

Larry H. Bernstein, mD, FCAP, Curator

https://pharmaceuticalintelligence.com/2016/05/08/molecular-basis-for-schizophrenia/

 

• Schizophrenia, broken-links

Larry H. Bernstein, MD, FCAP, Curator

https://pharmaceuticalintelligence.com/2016/04/05/schizophrenia-broken-links/

 

• Schizophrenia genomics

Larry H. Bernstein, MD, FCAP, Curator

https://pharmaceuticalintelligence.com/2016/03/15/schizophrenia-genomics/

 

• Imaging Schizophrenia Brain

Larry H. Bernstein, MD, FCAP, Curator

https://pharmaceuticalintelligence.com/2015/10/27/schizophrenia-brain/

 

• Outstanding Achievement in Schizophrenia Research

Larry H. Bernstein, MD, FCAP, Curator

https://pharmaceuticalintelligence.com/2015/09/06/outstanding-achievement-in-schizophrenia-research/

 

 

5/24/2019

Resources on Artificial Intelligence in Health Care and in Medicine: Articles of Note at PharmaceuticalIntelligence.com @AVIVA1950 @pharma_BI

https://www.linkedin.com/pulse/resources-artificial-intelligence-health-care-note-lev-ari-phd-rn/

 

5/22/2019

Leaders in Pharmaceutical Business Intelligence Group (“LPBI Group”) is an electronic scientific publishing venture that has developed proprietary, advanced platform architecture methodologies and business models, i.e., combination drug therapies, conceptual drug designs and forecasting demand models. Through the creation of original scientific content using a methodology of curation of scientific findings that they have developed and implemented since 4/2012, LPBI Group became a powerhouse for curation of scientific findings and methodology development for e-scientific publishing, growing its journal archive to +5,500 articles.

The Group has three interrelated healthcare content products: an open-access online scientific journal; a series of 16 BioMed e-books; and real-time coverage of BioMed scientific and medical conferences. Through these transformative products, the Group effectively meets and exceeds the information needs of researchers, scientists and industry pharmaceutical and biotechnology executives by offering real-time and currently available medical and scientific information on any biomedical subject (700 categories).  Please visit us at http://pharmaceuticalintelligence.com and on Twitter (@pharma_BI, @Aviva1950).

 

5/21/2019

Updated Profile of Leaders in Pharmaceutical Business Intelligence (LPBI) Group

https://lnkd.in/desCCx7

Expertise of our Team members includes functional areas of the e-Scientific Publishing segment https://lnkd.in/ejXnvUN

• Our IP is most valuable for several industrial sectors and economic segment as described https://lnkd.in/dNHYWGH

• We offer several Media Distribution Channels for Contents and Events as described https://lnkd.in/dnHVBKv

• We welcome partnerships and inter-organizational interfaces for collaboration purposes. We are seeking Joint Ventures, M&A and other structures to leverage our IP and the deep expertise of our Team Contact us

 

5/20/2019

 

Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Newton, MA is a venture launched on April 2012.

LPBI Group is a start up that developed content in the following domains:

Our DOMAINS in Scientific Media

I.    Pharmaceutical: Biologics, Small Molecules, Diagnostics

II.  Life Sciences: Genomics and Cancer Biology

III.  Patient-centered Medicine: Focus on #1: Cardiovascular, #2: Cancer, #3: Physiology Metabolomics, Immunology

IV.  Biomedicine, BioTech, and MedTech (Medical Devices)

V.   HealthCare: Patient-centered Medicine and Personalized/Precision Medicine

OUR three health care Intellectual Property (IP) Content Asset Classes:

• IP Asset Class I: Corpus of 5,600 Scientific Articles in the Open Access Journal @PharmaceuticalIntelligence.com

https://lnkd.in/erfbayJ

• IP Asset Class II: Corpus of 16 Volumes in LPBI Group’s BioMed e-Series

https://lnkd.in/ekWGNqA

• IP Asset Class III: Corpus of +60 Conference eProceedings

https://pharmaceuticalintelligence.com/press-coverage/

 

5/17/2019

LIVE 2019 Petrie-Flom Center Annual Conference: Consuming Genetics: Ethical and Legal Considerations of New Technologies, Friday, May 17, 2019 from 8:00 AM to 5:00 PM EDT

https://pharmaceuticalintelligence.com/2019/01/11/2019-petrie-flom-center-annual-conference-consuming-genetics-ethical-and-legal-considerations-of-new-technologies/

 

Tweets and Re-Tweets by @Pharma_BI ‏and @AVIVA1950 at 2019 Petrie-Flom Center Annual Conference: Consuming Genetics: Ethical and Legal Considerations of New Technologies, Friday, May 17, 2019 from 8:00 AM to 5:00 PM EDT @Harvard_Law

https://pharmaceuticalintelligence.com/2019/05/20/tweets-and-re-tweets-by-pharma_bi-%e2%80%8fand-aviva1950-at-2019-petrie-flom-center-annual-conference-consuming-genetics-ethical-and-legal-considerations-of-new-technologies-friday-may/

 

5/12/2019

LIVE 13th Annual BioPharma &amp; Healthcare Summit, Thursday, May 9, 2019, Marriott Hotel, Cambridge, MA

https://pharmaceuticalintelligence.com/2019/04/30/13th-annual-biopharma-healthcare-summit-thursday-may-9-2019/

Tweets and Retweets by @AVIVA1950 and by @pharma_BI for @USAIC and #USAIC2019 at the 13th Annual BioPharma & Healthcare Summit, Thursday, May 9, 2019, Marriott Hotel, Cambridge, MA

https://pharmaceuticalintelligence.com/2019/05/12/tweets-and-retweets-by-aviva1950-and-by-pharma_bi-for-usaic-and-usaic2019-at-the-13th-annual-biopharma-healthcare-summit-thursday-may-9-2019-marriott-hotel-cambridge-ma/

 

5/6/2019

Dr. Lev-Ari was solicited by MIT Inclusive Innovation Challenge (MIT IIC) to register for 2019 applicant pool of entrepreneurs developing digital technologies for the workplace.

The IIC is the flagship program of the MIT Initiative on the Digital Economy, annually celebrating entrepreneurs who are using technology to create innovative solutions to global challenges. Global Winners will receive the award at the Global Grand Prize Gala at MIT. In the last three years, the IIC has awarded 100 organizations around the world. View past winners.

https://challenge.mitinclusiveinnovation.com/applications/2900/printable

5/2/2019

 

5/1/2019

1.  You Retweeted

   Aviva Lev-Ari‏ @AVIVA1950 May 1

   More

   @Harvard #innovationLab 8th Annual President’s Innovation Challenge Award Ceremony begins Change the World ⁦@jodigoldstein⁩ #Leaders #culture #innovation #celebrate #failure $1.5Billion raised 54% female applicants 50% applicant of color ingenuity Awards ⁦@Pharma_BI⁩

   0:33

   18 views

   0 replies2 retweets2 likes

   Reply

   Retweeted

   2

   Liked

   2

   View Tweet activity
2.  You Retweeted

   Stephen J Williams‏ @StephenJWillia2 May 1

   More

   Stephen J Williams Retweeted Aviva Lev-Ari

   #TUBiol3373

   Stephen J Williams added,

   

   Aviva Lev-Ari @AVIVA1950

   @Pharma_BI @AVIVA1950 Make this World a better place, students you are the FUTURE. 20 final teams finalists to pitch in 15 seconds #human #health #Lab to #bedside 5 finalist Flotherm, GC therapeutics, Kinnos, Lima…

   0 replies1 retweet1 like

   Reply

   Retweeted

   1

   Liked

   1

   Direct message

1.  You Retweeted

   Aviva Lev-Ari‏ @AVIVA1950 May 1

   More

   ⁦@Harvard⁩ 2019 President’s Innovation Challenge Showcase & Award Ceremony 4 categories: #HealthLifeScience #socialImpact #OpenTrack #LaunchLabX @AVIVA1950 ⁦@Pharma_BI⁩

   

   0 replies1 retweet1 like

   Reply

   Retweeted

   1

   Liked

   1

   View Tweet activity
2.  You Retweeted

   Aviva Lev-Ari‏ @AVIVA1950 May 1

   More

   ⁦@Pharma_BI⁩ @AVIVA1950 #PIC2019 #SocialImpact category Coding it Forward, JustFix is the Winner, Generus, MDaas Global MRI to Africa, New Teachers Thriving (GDE),

   

   0 replies1 retweet3 likes

   Reply

   Retweeted

   1

   Liked

   3

   View Tweet activity
3.  You Retweeted

   Aviva Lev-Ari‏ @AVIVA1950 May 1

   More

   #PIC2019 ⁦@Pharma_BI⁩ @AVIVA1950 #OpenTrack LeverEdge, MyToolBox- is the winner, http://Porto.ai , ReThink- Grand Prize, Voodles,

   

   0 replies1 retweet2 likes

   Reply

   Retweeted

   1

   Liked

   2

   View Tweet activity
4.  You Retweeted

   Aviva Lev-Ari‏ @AVIVA1950 May 1

   More

   #PIC2019 ⁦@Pharma_BI⁩ @AVIVA1950 five teams solutions for CHANGING THE WORLD, Jamber-Grand Prize winner, Legacy, Nilus, Sophia -the winner, Zubale,

   

   0 replies1 retweet2 likes

   Reply

   Retweeted

   1

   Liked

   2

   View Tweet activity
5.  You Retweeted

   Aviva Lev-Ari‏ @AVIVA1950 May 1

   More

   #PIC2019 INGINUITY Award, 300 applications 200 advisors. Awards for ingenuity: Three ideas $2500 increase Teachers, GES, $2500 child care edu, GSB, $5,000 Steel manufacturing waste silicon instead of CO2. ⁦@Pharma_BI⁩ @AVIVA1950

   

   0 replies1 retweet2 likes

   Reply

   Retweeted

   1

   Liked

   2

   View Tweet activity

4/30/2019

1. Aviva Lev-Ari‏ @AVIVA1950 Apr 30

   More

   ⁦@MGHCancerCenter⁩ #AI to read memo grams for prediction of future cancer age family history prior procedure 42% density out 212K 8 have dense deep neural network model image vs model image +RF DL white vs non white high Risk Density bias free ⁦@Pharma_BI⁩ @AVIVA1950

   

   0 replies0 retweets0 likes

   Reply

   Retweet

   Like

   View Tweet activity
2. Aviva Lev-Ari‏ @AVIVA1950 Apr 30

   More

   ⁦@MIT⁩ ⁦@kochinstitute⁩ ⁦@Pharma_BI⁩ @AVIVA1950 #breastcancer o accurate tools for early detection or predicts future disease progression or remission 6 out of 200,000 images will are cancer variation of image interpretation breast density for notification

   

   0 replies0 retweets0 likes

   Reply

   Retweet

   Like

 

 

4/25/2019

 

Tweets by @pharma_Bi and @AVIVA1950 at #GenMed2019 on Translating Genetics into Medicine, April 25, 2019, 8:30 AM – 6:00 PM, The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

https://pharmaceuticalintelligence.com/2019/04/25/tweets-by-pharma_bi-and-aviva1950-at-genmed2019-on-translating-genetics-into-medicine-april-25-2019-830-am-600-pm-the-new-york-academy-of-sciences-7-world-trade-center-250-greenwi/

 

LIVE – Translating Genetics into Medicine, April 25, 2019, 8:30 AM – 6:00 PM, The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Real Time Press Coverage: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2019/04/25/translating-genetics-into-medicine-april-25-2019-830-am-600-pm-the-new-york-academy-of-sciences-7-world-trade-center-250-greenwich-st-fl-40-new-york/

 

4/22/2019

@AVIVA1950 SUMALL Weekly Digest	04/07/2019 – 04/13/2019 #WMIF19 04/08/2019 – 04/10/2019
Likes	125
Followers	391
Friends	1.5K
Mentions Reach	23.7K
Mentions	14
Replies	0
Retweet Reach	130.4K
Retweets	66
Tweets	154

SOURCE

From: SumAll <sumall@sumall.com>

Date: Monday, April 22, 2019 at 4:35 AM

To: “<Aviva Lev-Ari>”, <PhD>, Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: My Weekly Digest: Week of Apr 14, 2019

 

 

4/22/2019

We met a MILESTONE on 4/19/2019 – we sent out to NY two documents of great significance.

The CHARTER during an Interim Period – AVIVA’s VISION POST 4/19/2019

 

a. Create strategic directions for current LPBI Group IP Asset Classes: I, II, III

b. Lay out the foundation for LPBI Group’s newly defined pipelines in Document #2 – our future legacy following the 16th e-Book completion in 2019.

b.1 Potential emergence of e-Book #17

—->>>> Major discovery in Cell Journal @UCSF on B cells impact on immunology and vaccine design – let to a new project I launched yesterday:

• MWF to get Full Document
• Dr. Saha to write new curation
• Dr. Williams to comb the archive on B Cells research
• Dr. Irina to Update 6 existing B cell articles in the Journal with URL of Dr. Saha’s new curation
• Dr. Irina to write impact of Dr. Saha’s curation content on Vaccine Design
• Dr. Larry to review all of the above
• If Dr. Williams is fetching a pool of existing B Cell articles in our Journal to be >60, THEN
• Aviva to launch Series D, Volume 4 on B Cell in Vaccine Design

Series D, Volume 4: Editors: Saha, Williams, Irina, Aviva

THIS WILL BE THE FIRST BOOK IN EXISTENCE on the 2019 discovery @UCSF on new roles for B cells beyond production of antibodies

c. Gradually build capabilities of LPBI Group’s Specialty in Consulting using IP Asset Class IV: Business Methods applIed in Biotech for Biotech and Pharma, where Business Side and our Scientists (newly, to be recruited) work jointly on Client assignments using our IP Asset Classes: I, II, III, IV.

—>>> Business side get engagements —>>> Scientists side develop and deliver on engagement

ALL,

Till we learn from IB about 

—->>>>> “are we a NEW Client of xxxx, Investment Banker, NY:  yes or no”

• We may get second round of RFI from the IB before that decision is made

WE shift focus to OTHER activities:

1. Gail’s Marketing Communications initiatives:

1.1 Podcasts on our e-Books:

– 3D BioPrinting, May 3

–  Voices of Patients, date TBD

1.2 Newsletter —  I update LPBI Group News, Gail uses this content and other content

2. WE focus all FIT Scientists on @UCSF Discovery on B Cells, as above 

3. WE work to publish Genomics Volume 2 in 2019.

4. Amnon and Rick continue to work on Business Development concepts – Plan B

5. KICK OFF SKYPE SESSION ALL FIT MEMBERS in May 2019 – Date/Time: TBD, Organizer: Irina

 

4/20/2019

CONGRATULATIONS to Amnon, Gail and Rick for bringing to completion thie OWN initiative to create a Business Plan for LPBI Group.

Amnon:

I am happy that you demonstrated to me your thought process. You were given a difficult challenge, taking the ball and running with it, is a very high bar to jump, you did it beautifully on several levels:

1. You challenged yourself

2. You produced artifacts that I could use “as is” into my own work on Document #2 – key 🔑 for me to extend my capabilities

3. Now, I know HOW to activate you for high qualitative outcomes in concept formation

THANKS to Gail and Rick:

4. You on your own, with my suggestion, activated Gail and Rick to produce significant artifacts

5. Together, the three produced the first version of the LPBI Group’s Business Plan

6. It had the originality I am seeking when I say, “teach me something new.” Because, I always need more building blocks to generate new IP

7. Taking it all together, I gained the confidence that Business Side on LPBI Group’s FIT can and will continue to build IP Asset Class IV: Business Methods which has few potentials

 

4/14/2019

The #WMIF19 Influencers via @symplur‘s #Healthcare Hashtags http://bit.ly/WMIF19 – By Mentions and By Tweets Ranked #4: @pharma_BI and #2: @AVIVA1950, respectively. Ranked #3 via NodeXL Betweenness Centrality http://bit.ly/2KB6cPN

https://pharmaceuticalintelligence.com/2019/04/13/the-wmif19-influencers-via-symplurs-healthcare-hashtags-http-bit-ly-wmif19-by-mentions-and-by-tweets-ranked-4-pharma_bi-and-2-aviva1950-respectively-ranked-3-via-node/

4/13/2019

Twitter Data for LPBI Group’s Founder’s Twitter handle @AVIVA1950 was updated 

On 2/24/2019 — Tweets 8,060 Following 1,412 Followers 359 Likes 2,752

On 4/13/2019 — Tweets 9,018 Following 1,461 Followers 390 Likes 3,654

1. In 48 days # Follower increases from 359 to 390 – Growth rate of 8%
2. Three new “I” Followers were selected to be added in 48 days since 4/24/2019 = 25,667 Followers of Followers
3. Eight new “P” Followers were selected to be added in 48 days since 4/24/2019 = 425,971 Followers of Followers
4. Total “I” + “P” on 2/24/2019 was 2,580,051
5. Total “I” + “P” on 4/13/2019 was 3,031,689
6. Growth Rate of Followers’ Followers 17.5% in 48 days

Thus, on 4/13/2019 the Followers DATA in the Excerpt is base on 117 on 2/24/2019 plus 11 [2 and 3, above] = 128 Followers 

 

4/13/2019

@symplur‘s #Healthcare Hashtags – Twitter Analytics published for http://bit.ly/WMIF19 

• [Top 10 by Mentions – @pharma_BI = 4 with 181 mentions]  
• [Top 10 by Tweets @AVIVA1950 = 2 with 229 Tweets (N = 152 Direct messages)]

 Pinned Tweet

Irma 

✨

in #Boston‏ @IrmaRaste Apr 10

More

As World #Medical #Innovation Forum comes to a close, here are TOP #WMIF19 #influencers via @symplur‘s #Healthcare Hashtags

to organizers for a stellar event & to all on #MedTwitter for a robust conversation! #AI @PHSInnovation @ChrisMarkCOBURN 

http://bit.ly/WMIF19 

Partners HealthCare, GE Healthcare, Brigham Digital Innovation Hub and 6 others

3 replies

12 retweets

15 likes

Direct message

 

4/11/2019

Top 3 Ranked by Betweenness Centrality in Top 10 Influencers #WMIF19 @phsinnovation @evankirstel @aviva1950 –Tweeter Analytics by NodeXL http://bit.ly/2KB6cPN for #WMIF19 by @PHSInnovation  at World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 8-10, 2019

https://pharmaceuticalintelligence.com/2019/04/11/top-3-ranked-by-betweenness-centrality-in-top-10-influencers-wmif19-phsinnovation-evankirstel-aviva1950-tweeter-analytics-by-nodexl-http-bit-ly-2kb6cpn-for-wmif19-by-phs/

Tweets, ReTweets and Likes by @AVIVA1950 and by @pharma_BI using @PHSInnovation and #WMIF19 during Day One, Two and Three of World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 8-10, 2019

https://pharmaceuticalintelligence.com/2019/04/11/tweets-retweets-and-likes-by-aviva1950-and-by-pharma_bi-using-phsinnovation-and-wmif19-during-day-one-two-and-three-of-world-medical-innovation-forum-artificial-intelligence-boston-ma-us/

 

LIVE Day One – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Westin Copley Place, Boston, MA USA, Monday, April 8, 2019

https://pharmaceuticalintelligence.com/2019/04/08/live-day-one-world-medical-innovation-forum-artificial-intelligence-westin-copley-place-boston-ma-usa-monday-april-8-2019/

 

LIVE Day Two – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 9, 2019

https://pharmaceuticalintelligence.com/2019/04/09/live-day-two-world-medical-innovation-forum-artificial-intelligence-boston-ma-usa-monday-april-9-2019/

 

LIVE Day Three – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 10, 2019

https://pharmaceuticalintelligence.com/2019/04/10/live-day-three-world-medical-innovation-forum-artificial-intelligence-boston-ma-usa-monday-april-10-2019/

 

4/2/2019

Total 2,241,388

• [Media 375,606] 

Institutions (I) – Total 1,786,443

• [Media Companies 341,716]

Individuals (P) – Total 430,725

• [Media Individuals 13,390]

LPBI Group is mostly honored to have its Founder’s Twitter handle @AVIVA1950 been followed by top Scientific research organization who are leaders in e-Scientific content production, chiefly,

 

Technion Israel	@TechnionLive	47,800 followers
Broad Institute	@MIT @HARVARD @broadinstitute	46,000 followers

 

See all @AVIVA1950 that we declared as “mostly honored to be followed by”

 

• Mostly HONORED to be followed by [from an Excerpt of 117 Followers of the Twitter Account @AVIVA1950 from the List of 359 Followers] by the Number of their Followers on 2/24/2019

https://pharmaceuticalintelligence.com/2019-vista/mostly-honored-to-be-followed-by-from-an-excerpt-of-117-followers-of-the-twitter-account-aviva1950-from-the-list-of-359-followers-by-the-number-of-their-followers-on-2-24-2019/

 

3/29/2019

TWEETS and Retweets by @pharma_BI and @AVIVA1950 on Day One and Day Two: 2019 MassBio Annual Meeting, State of Possible Conference, Sonesta Hotel, Cambridge, March 27, 2019

https://pharmaceuticalintelligence.com/2019/03/29/tweets-and-retweets-by-pharma_bi-and-aviva1950-on-day-one-and-day-two-2019-massbio-annual-meeting-state-of-possible-conference-sonesta-hotel-cambridge-march-27-2019/

 

LIVE Day Two: 2019 MassBio Annual Meeting, State of Possible Conference, Sonesta Hotel, Cambridge, March 28, 2019

https://pharmaceuticalintelligence.com/2019/03/28/live-day-two-2019-massbio-annual-meeting-state-of-possible-conference-sonesta-hotel-cambridge-march-28-2019/

 

LIVE Day One: 2019 MassBio Annual Meeting, State of Possible Conference, Sonesta Hotel, Cambridge, March 27, 2019

https://pharmaceuticalintelligence.com/2019/03/27/live-day-one-2019-massbio-annual-meeting-state-of-possible-conference-sonesta-hotel-cambridge-march-27-2019/

 

3/21/2019

Announcement

Amnon Danzig, FIT member, our Strategic Thinker, will be presenting a 20 minute Conference Presentation at the Second Global Conference on Creating Value on May 14-15, 2019 at Fordham University’s Gabelli School of Business at 140 West 62nd Street in New York City.

The details of the conference program will be listed on the conference website soon. For updates, please check  

http://www.creatingvalue.co/creating-value-conference-programme/

SOURCE

From: Global Creating Value 2019 <creatingvalue2019@fordham.edu>

Date: Wed, Mar 20, 2019, 15:32

Subject: Second Global Conference on Creating Value – Presenter Information

To: Fordham Creatingvalue2019 <creatingvalue2019@fordham.edu>

Sertan Kabadayi, PhD

Conference Co-chair

Area Chair – Marketing 

Professor of Marketing

Gabelli School of Business 

Fordham University- Lincoln Center

140 West 62nd Street, Suite 446

New York, NY, 10023

Phone: 212.636.7804

Email: Kabadayi@Fordham.edu

www.fordham.edu/sertan-kabadayi

www.fordham.edu/marketing-area

 

3/21/2019

Announcement

LPBI Group will be covering in Real Time 2019 18th BioIT Conference on 4/16/2019 – 4/18/2019 at Seaport World Trade Center, Boston, MA.

 

 

Aviva Lev-Ari, PhD, RN

https://lnkd.in/eEyn69r

will be in attendance in Real Time generating the conference e-Proceedings and on Social Media using

#BioIT2019

and

pharmaceuticalintelligence.com

@pharma_BI

Official LPBI Twitter account

@AVIVA1950

Aviva Lev-Ari, PhD, RN Private Twitter account

 

SOURCE

Cambridge Healthtech Institute 250 First Avenue Suite 300 Needham, Massachusetts 02494 Phone: 781-972-5400 Fax: 781-972-5425
To: Dr Aviva Lev-Ari   Dir & Founder   HQS Leaders in Pharmaceutical Business Intelligence   83 Mandalay Rd   NEWTON, MA 02459 USA   Phone: 617-244-4024   Fax: _____-_____-________   Email: avivalev-ari@alum.berkeley.edu	Date: 03/20/2019 Invoice No: 534129 Registration No: 534129 PO No:
You Are Registered for: BioIT World Conference & Expo Conference Code: BIT192000 Dates: 04/16/2019 – 04/18/2019 Conference Location: Seaport World Trade Center   Boston, MA 02210 USA   Phone: 617-385-5049 Fax:
Date Ref # Description Price ($) 03/20/2019 Press Pass: .00 Balance Due .00

 

3/12/2019

Our WEBSITE is NOW on a Business Site Plan – What does that mean

We need to

• CUSTOMIZATION of the Website
• e-Mail @pharmaceuticalintelligence.com

Our WEBSITE is NOW on a Business Site Plan – What does that mean

powerful tools and support included in enhanced WordPress.com plans that can help fast-track the success of your site, whatever your goals may be.

With an upgraded site you can:

• Impress your friends with your very own domain name (instead of having WordPress.com in your URL).
• Quickly resolve any roadblocks by connecting with our all-star customer service team through live-chat support.
• Bring your design vision to life with over 100 professionally designed templates to choose from.
• Gain complete control of your site when you unlock custom CSS capabilities (Premium, Business, and eCommerce plans).
• Build your community, connect with customers, or grow your business with enhanced marketing and eCommerce tools.

Hi 2012pharmaceutical,

We’re excited that you purchased the Business plan on pharmaceuticalintelligence.com. It’s the perfect way to supercharge your site with advanced SEO tools, Google Analytics, free Premium themes, and more.

As part of your Business plan, you can schedule a free, personalized concierge session with one of our Happiness Engineers for real-time, one-on-one help. Just choose a time that works for you in the link below:

Schedule Now

We’ll answer any questions you have, and we’ll show you some of the awesome features that come with your Business plan. You can also reply to this email with any questions, or reach us via live chat at https://wordpress.com/help/contact.

Professional email and so much more

Make the right first impression and promote your website every time you send an email with an account @pharmaceuticalintelligence.com.

Get My Personalized Email

We’ve teamed up with Google Cloud to offer you professional email and a suite of productivity tools, including:

	Gmail for @pharmaceuticalintelligence.com Professional ad-free email that works with most email clients.
	Keep all your files secure Get 30GB of storage for all your files, and access them from your phone, tablet, or computer.
	Docs, spreadsheets and forms Create and edit documents at the same time as others to get your work done faster.
	Connect with your team Use text chats, voice calls, or video calls, with built in screen sharing.

Don’t wait — get the first two months free when you add G Suite to your site today.

Get My Personalized Email

The WordPress.com Team

How to Plan for a Successful Website Welcome to WordPress.com! We want to share some resources to help you build the perfect site for your business. Starting out, you might think that your site’s design is the primary consideration when building a successful website. In reality, your site’s content — the information and photos on your pages — does all the talking for you when you can’t be there to speak with your customers in person. Not sure where to begin? Check out your top three competitors’ websites. Which pages do they have? List them. How do they organize their pages into menus to form site navigation? Looking for further inspiration? Check out Measure Twice, Cut Once, an article that covers site pages and content planning. Learn more about how to create pages and navigation menus to structure your site: Add new pages to your site Organize your pages with a navigation menu Need a hand? In our next email, we will be sharing tips on how to pick the perfect theme to showcase your content. In the meantime, if you have any questions we’d love to help.

3/12/2019

Covering this event in Real Time @pharma_BI @AVIVA1950

2019 Koch Institute Symposium – Machine Learning and Cancer, June 14, 2019, 8:00 AM-5:00 PM ET MIT Kresge Auditorium, 48 Massachusetts Ave, Cambridge, MA

https://pharmaceuticalintelligence.com/2019/03/12/2019-koch-institute-symposium-machine-learning-and-cancer-june-14-2019-800-am-500-pmet-mit-kresge-auditorium-48-massachusetts-ave-cambridge-ma/

 

3/2/2019

• Excerpt of 117 Followers of @AVIVA1950 (from the List of 359 Followers) by the Number of their Followers

• Institutional Follower’s Followers = 1,354,885  

• Individual (person) Follower’s Followers =1,157,741 

• Number of Followers of @AVIVA1950 117 Followers –>>>>> Total 2,512,626

HIGHEST HONOR to be followed by                   [From an Excerpt of 117 Followers of @AVIVA1950 (from the List of 359 Followers)] by the Number of their Followers		Aviva Lev-Ari	Institutional Follower’s Followers = 150,617         Individual (person) Follower’s Followers = 345,000         Total = 495,617
Tweets 8,060	Following 1,412	Followers 359	Likes 2,752
I = Institution   P = Person         RED = Highest HONOR to be Followed by	Follower Name	Twitter Handle	# of Followers
I	Technion Israel	@TechnionLive	47,800
I	Broad Institute	@MIT @HARVARD @broadinstitute	46,000
I	NFCR	@NFCR	36,100
I	Technion T³	@TechnionT3	16,900
I	BCM_CVRI	@BCM_CVRI	2,249
I	Partners Innovation	@PHSInnovation	1,121
I	Discovery on Target	@BostonDOT	298
I	PM Conference	PM Conference	149
Total of “I”			150,617
P	Dr Atanas G Atanasov	@_atanas_	107,000
P	Eric Rodgers	@ericfrodgers	87,700
P	Dr. GP Pulipaka	@gp_pulipaka	54,400
P	Jan Oldenburg	@janoldenburg	23,000
P	BioInformant	@StemCellMarket	21,300
P	Dr. Stefan Gruenwald	@sgruenwald	21,100
P	John Belmont	@jwbelmon	17,900
P	Richard G. Lanzara	@rlanzara	8,740
P	Dr. Thomas Wilckens	@Thomas_Wilckens	2,596
P	Yuval Cohen	@CEOCorbus	1,264
Total “P”			345,000

FIT Members Tweet to Followers of

  @AVIVA1950

Tweet by Prof. Feldman

@broadinstitute @BioWorld @Biotech365 @pharma_BI @AVIVA1950 e-Journal pharmaceuticalintelligence.com ebooks https://lnkd.in/ekWGNqA Conference eProceedings DELIVERABLES & Social Media Analytics #RealTime #Press Looking forward to continued collaboration with @pharma_BI @AVIVA1950 supporting mutual efforts to promote #pharmanews #biotech #personalized #medicine #BioMedical #biotechnology #biopharma #science #research #pharmaceutical

 

Tweet by Dr. Williams

@TechnionLive @BostonDOT @PharmaVoice Looking forward to continued collaboration with @pharma_BI @AVIVA1950 supporting mutual efforts to promote #pharmanews #biotech #personalizedmedicine @StephenJWillia2

 

TWEET by Rick Mandahl

@NFCR @pharma_BI @AVIVA1950 e-Journal pharmaceuticalintelligence.com #cancer #biology #oncology #genomics #curations #realtime #cancer #researchers #globally #exploratory #discussions for #collaboration ebooks https://lnkd.in/ekWGNqA Conference eProceedings DELIVERABLES & Social Media Analytics

TWEET by Rick Mandahl

@PMC #Conference @harvardmed #patients #researchers #policymakers #health #pharma #execs #insurers – dedicated to improving #patient #outcomes #genomic #science #medicine #Collaborate #president @PMC #announcements #Realtime covered #Annual #Conference over 2 million LPBI followers #personalized #medicine to improve #Global #health @pharma_BI @AVIVA1950

TWEET by Rick Mandahl

@TechnionT3 #scientific #engineering #medical #research @Israel #innovation @global #progress @Boston @pharma_BI @AVIVA1950 e-Journal pharmaceuticalintelligence.com #cancer #biology #oncology #genomics #curations #realtime #cancer #researchers #globally #exploratory #discussions for #collaboration ebooks https://lnkd.in/ekWGNqA Conference eProceedings DELIVERABLES & Social Media Analytics over 1.6 million #global #eReaders including @TechnionT3 consider #strategy using @pharma_BI #IP for #progress of @TechnionT3 #dynamics. Let’s explore #joint #venture

 

Irina Robu, PhD

@broadinstitute @PHSInnovation   @BostonDOT @StemCellMarket Looking forward to continuous partnership with @pharma_BI @AVIVA1950 supporting common efforts to promote #tissue engineering #biomaterials #stemcells #biotech #cell therapy #personalized #medicine @irirobu

 

TWEETS by AMNON to @AVIVA1950 Most Honored to be followed by Followers

@TechnionLive @amnon_danzig  Two #strategic #structural #risks in @Scientific #Publishing for all #Scientists: #Information #Explosion, and the high rate of #Information #Obsolescence #Curation #Methodologies and #Data #Science serves as #mitigating #factors pharmaceuticalintelligence.com @pharma_BI curation methodology developed by @AVIVA1950  https://lnkd.in/eEyn69r  is a #leader in the #complex #BioMed #field https://lnkd.in/ekWGNqA

@TechnionT3 @amnon_danzig  Technology transfer requires the most relevant and up-to-date knowledge of all technologies pharmaceuticalintelligence.com @pharma_BI #curation #methodology developed by @AVIVA1950 https://lnkd.in/eEyn69r  is a #leader in the #complex #BioMed #field https://lnkd.in/ekWGNqA #KnowledgeGap needs be narrowed for #successful #TechnologyTransfer

@PHSInnovation @amnon_danzig  #invention or #innovation? Invention is a #technological #breakthrough while most #Innovation are born by #interdisciplinary cross #fertilization #Leaders in #curation #methodology developed by @AVIVA1950 https://lnkd.in/eEyn69r in #BioMed #fields https://lnkd.in/ekWGNqA pharmaceuticalintelligence.com @pharma_BI in #Medicine #LifeSciences #HealthCare #MedTech #BioTech #DrugDiscovery #PharmaceuticalIntelligence

 

2/18/2019

• Founder’s Role in the Development of Venture’s Factors of Content Production – Biographical Notes by Aviva Lev-Ari, PhD, RN, LPBI Group
• FIT Members Contribute to Opportunities Map

2/3/2019

LIST OF ASSETS

• Launched Open Access Online Scientific Journal @PharmaceuticalIntelligence.com, 4/2012

https://lnkd.in/erfbayJ

• Launched BioMed eSeries, 16-Volumes in Life Sciences and Medicine, 10/2012

Launched 6 Volumes #Cardiovascular e-Series, Bundled on Amazon for $515 

https://lnkd.in/e6WkMgF

Launched 10 Volumes in #Medicine #Genomics 1,2  #Cancer 1,2 #Immunology 1,2,3  #PrecisionMedicine 1,2,3,4

https://lnkd.in/ekWGNqA

• Launched Real Time Press Coverage of Biotech Conferences, 3/2013

https://pharmaceuticalintelligence.com/press-coverage/

Part One: The Process of Real Time Coverage using Social Media

Part Two: List of BioTech Conferences 2013 to Present

Part Three: Conference eProceedings DELIVERABLES & Social Media Analytics

2/1/2019

TWITTER Handles

@pharmaceuticalintelligence.com

@pharma_BI

@AVIVA1950

https://lnkd.in/erfbayJ

1/31/2019

TWEETS by @pharma_BI and @AVIVA1950 at #IESYMPOSIUM – @kochinstitute 2019 #Immune #Engineering #Symposium, 1/28/2019 – 1/29/2019

Real Time Press Coverage: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2019/01/31/tweets-by-pharma_bi-and-aviva1950-at-iesymposium-kochinstitute-2019-immune-engineering-symposium-1-28-2019-1-29-2019/

 

1/29/2019

LIVE Day One – Koch Institute 2019 Immune Engineering Symposium, January 28, 2019, Kresge Auditorium, MIT

https://pharmaceuticalintelligence.com/2019/01/28/live-day-one-koch-institute-2019-immune-engineering-symposium-january-28-2019-kresge-auditorium-mit/

 

LIVE Day Two – Koch Institute 2019 Immune Engineering Symposium, January 29, 2019, Kresge Auditorium, MIT

https://pharmaceuticalintelligence.com/2019/01/29/live-day-two-koch-institute-2019-immune-engineering-symposium-january-29-2019-kresge-auditorium-mit/

 

1/26/2019

Team Tweets

 

#1 – ALL BioMed 16 Volumes

@Amazon BUNDLED @pharma_BI @AVIVA1950 https://lnkd.in/eEyn69r

6 Volumes #Cardiovascular for $515 https://lnkd.in/e6WkMgF

UNBUNDLED 10 Volumes in #Medicine https://lnkd.in/ekWGNqA

 #Genomics 1,2  #Cancer 1,2 #Immunology 1,2,3  #PrecisionMedicine 1,2,3,4

 

#2 – Please Tweet – about Series E

 

@Amazon @pharma_BI BUNDLES for $274 #Patients #Voices #Precision #Medicine #Physiology #Genomics #Therapeutics #3D #BioPrinting: Series E: Volumes 1,2,3,4 by Editors: Larry H Bernstein @bernstein_h  Gail Thornton @GailThornt  Aviva Lev-Ari @AVIVA1950 ‏https://lnkd.in/ekWGNqA

 

#3 – Please Tweet – about Series C

 

Amazon @pharma_BI BUNDLES for $175 Series C: #Cancer #Oncology

VOLUME 1 Cancer #Biology #Genomics  http://www.amazon.com/dp/B013RVYR2K

VOLUME 2 #Therapies Genomics #Interventional #Immunotherapy #Nanotechnology in #Drug #Delivery  http://www.amazon.com/dp/B071VQ6YYK

 

#4 – Please Tweet – about Series D

 

@Amazon @pharma_BI BUNDLES for $190 Series D: #Metabolomics #Immunology #Infectious #Diseases VOLUME 1 http://www.amazon.com/dp/B012BB0ZF0 VOLUME 2 & VOLUME 3 https://www.amazon.com/dp/B075CXHY1B

 

1/22/2019	e-Readers	# Articles	Scientific Comments	Research Categories
LPBI Group	1,563,240	5,469	7,308	666
Aviva Lev-Ari, PhD, RN	393,545	3,245

On 1/22/2019

‪#Updates‪ to 2018 1,562,778 e-Readers @pharma_BI @AVIVA1950 https://lnkd.in/eEyn69r 393,431views

‪#Bundled #CVD #Diseases – 6 Volumes https://lnkd.in/e6WkMgF

‪#Bundled #Cancer 1,2 #immunology 1,2,3 #PrecisionMedicine 1,2,3,4 https://lnkd.in/ekWGNqA

 

On 1/20/2019 – 280 character Tweet

@Amazon.com BUNDLED for $515 @pharma_BI a Six-volume e-Series on #Cardiovascular #Diseases https://www.amazon.com/dp/B07MVF34ZC/ref=sr_1_1?s=digital-text #Genomics #Cancer #Metabolomics, #Immunology, #Infectious #Diseases #Patient #Voices #Precision #Medicine 4 Volumes https://www.amazon.com/s/ref=nb_sb_noss?url=search-alias%3Ddigital-text&field-keywords=Aviva+Lev-Ari&rh=n%3A133140011%2Ck%3AAviva+Lev-Ari @AVIVA1950

 

On 1/16/2019

 

BUNDLED FOR $515 BY AMAZON.COM INTO A SIX-VOLUME SERIES

SERIES A: Cardiovascular Diseases

https://www.amazon.com/dp/B07MVF34ZC/ref=sr_1_1?s=digital-text

 

2019

• Koch Institute 2019 Immune Engineering Symposium, January 28-29, 2019, Kresge Auditorium, MIT

Real Time Press Coverage: Aviva Lev-Ari, PhD, RN

https://calendar.mit.edu/event/immune_engineering_symposium_2019#.XBrIDc9Kgcg

http://kochinstituteevents.cvent.com/events/koch-institute-2019-immune-engineering-symposium/event-summary-8d2098bb601a4654991060d59e92d7fe.aspx?dvce=1

• World Medical Innovation Forum, Partners Innovations, ARTIFICIAL INTELLIGENCE | APRIL 8–10, 2019 | Westin, BOSTON

Real Time Press Coverage: Aviva Lev-Ari, PhD, RN

https://worldmedicalinnovation.org/agenda-list/

• Translating Genetics into Medicine, April 25, 2019, 8:30 AM – 6:00 PM, The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Real Time Press Coverage: Aviva Lev-Ari, PhD, RN

• 13th Annual US-India BioPharma & Healthcare Summit, May 9, 2019, Marriott, Cambridge

Agenda Pending

Real Time Press Coverage: Aviva Lev-Ari, PhD, RN

• 2019 Petrie-Flom Center Annual Conference: Consuming Genetics: Ethical and Legal Considerations of New Technologies, May 17, 2019, Harvard Law School

Real Time Press Coverage: Aviva Lev-Ari, PhD, RN

http://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference

https://pharmaceuticalintelligence.com/2019/01/11/2019-petrie-flom-center-annual-conference-consuming-genetics-ethical-and-legal-considerations-of-new-technologies/

2018

On 12/23/2018 and on 12/24/2019 we published two e-Books in Series A: Cardiovascular Diseases

Pharmacological Agents in Treatment of Cardiovascular Diseases (Series A: Cardiovascular Diseases Book 5) Kindle Edition

by Justin D. Pearlman (Author), Larry H. Bernstein (Author),

Aviva Lev-Ari (Author)

On Amazon.com since 12/23/2018

Pharmacological Agents in Treatment of Cardiovascular Diseases (Series A: Cardiovascular Diseases Book 5)

Dec 23, 2018 | Kindle eBook

by Justin D. Pearlman and Larry H. Bernstein

$0.00

Subscribers read for free.

Read for Free

$115.00^$ 115 ⁰⁰ to buyKindle Edition

Get it TODAY, Dec 25

Sold by: Amazon Digital Services LLC

On Amazon.com

https://www.amazon.com/dp/B07MGSFDWR

https://www.amazon.com/dp/B07MGSFDWR

Electronic Table of Contents (eTOCs) for Volume 5 on LinkedIn

https://www.linkedin.com/pulse/pharmacological-agents-treatment-cardiovascular-book-aviva/

 

Detailed eTOCs

https://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/volume-five-pharmaco-therapies-for-cvd/

 

Interventional Cardiology for Disease Diagnosis and Cardiac Surgery for Condition Treatment (Series A: Cardiovascular Diseases Book 6) Kindle Edition

by Justin D. Pearlman (Author), Larry H. Bernstein (Author), Aviva Lev-Ari (Editor)

On Amazon.com since 12/24/2018

https://www.amazon.com/dp/B07MKHDBHF

Interventional Cardiology for Disease Diagnosis and Cardiac Surgery for Condition Treatment (Series A: Cardiovascular Diseases Book 6)

Dec 24, 2018 | Kindle eBook

by Justin D. Pearlman and Larry H. Bernstein

$0.00

Subscribers read for free.

Read for Free

$100.00^$ 100 ⁰⁰ to buyKindle Edition

Get it TODAY, Dec 25

Sold by: Amazon Digital Services LLC

https://www.amazon.com/dp/B07MKHDBHF

Electronic Table of Contents (eTOCs) for Volume 6 on LinkedIn

https://www.linkedin.com/pulse/interventional-cardiology-disease-diagnosis-cardiac-lev-ari-phd-rn/

 

Detailed eTOCs

https://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/volume-six-interventional-cardiology-and-cardiac-surgery/

 

 

 

@@@@

The Future of Precision Cancer Medicine, Inaugural Symposium, MIT Center for Precision Cancer Medicine, December 13, 2018, 8AM-6PM, 50 Memorial Drive, Cambridge, MA

https://pharmaceuticalintelligence.com/2018/11/28/the-future-of-precision-cancer-medicine-inaugural-symposium-mit-center-for-precision-cancer-medicine-december-13-2018-8am-6pm-50-memorial-drive-cambridge-ma/

 

New LINK, 12/4/2018:

2019 Strategic Marketing of LPBI Group’s Intellectual Property: Strength & Markets

https://pharmaceuticalintelligence.com/vision/2019-strategic-marketing-of-lpbi-groups-intellectual-property-strength-markets/

 

• LIVE eProceedings Day One – The 14th Annual Personalized Medicine Conference: PREPARING FOR THE NEW POSSIBLE, November 14, 2018, HMS, Boston

Real Time Press Coverage: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2018/07/18/the-14th-annual-personalized-medicine-conference-shifting-systems-insights-from-an-accelerating-global-push-toward-personalized-medicine-november-14-2018-hms-boston/

• LIVE eProceedings Day Two – The 14th Annual Personalized Medicine Conference: The Business of Personalization, November 15, 2018, HMS, Boston

Real Time Coverage: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2018/11/15/live-eproceeding-day-two-the-14th-annual-personalized-medicine-conference-the-business-of-personalization-november-15-2018-hms-boston/

• Tweets by @pharma_BI and @AVIVA1950 for The 14th Annual Personalized Medicine Conference: The Business of Personalization, November 15, 2018, HMS, Boston

Tweeter and Real Time Conference Press Coverage: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2018/11/16/tweets-by-pharma_bi-and-aviva1950-for-the-14th-annual-personalized-medicine-conference-the-business-of-personalization-november-15-2018-hms-boston/

 

LIVE 2018 The 21st Gabay Award to LORENZ STUDER, Memorial Sloan Kettering Cancer Center, contributions in stem cell biology and patient-specific, cell-based therapy

REAL TIME Reporter: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2018/10/09/live-2018-the-21st-gabay-award-to-lorenz-studer-memorial-sloan-kettering-cancer-center-contributions-in-stem-cell-biology-and-patient-specific-cell-based-therapy/

 

Nomination for 2018 Yidan Prize, recognition in the field of MEDICAL education: development of curation methodologies for scientific content – 2018 Nominee, Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2018/10/21/nomination-for-2018-yidan-prize-recognition-in-the-field-of-medical-education-development-of-curation-methodologies-for-scientific-content-2018-nominee-aviva-lev-ari-phd-rn/

 

The History, Uses, and Future of the Nobel Prize, 1:00pm – 6:00pm, Thursday, October 4, 2018, Harvard Medical School – Did not attend due to conflict

Reporter in Real Time: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2018/09/24/the-history-uses-and-future-of-the-nobel-prize-100pm-600pm-thursday-october-4-2018-harvard-medical-school/

New Posts in 2018

 

17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM

https://pharmaceuticalintelligence.com/2018/04/26/17th-annual-summer-symposium-breakthrough-cancer-nanotechnologies-koch-institute-mit-kresge-auditorium-june-15-2018-9am-4pm/

 

• IDEAS for Partnership and Funding to Advance our Mission —>> LPBI Group for the following purposes:

  1 Revitalize the Drug Discovery concepts for R&D in conjunction with Dr. Nir

  2 back-funding the IP value created for enabling near future transfer of ownership to a 

  not-for-profit organization or an NGO: I.e., 

  – Mass Academy of Sciences, 

  – Hadassah Medical Sciences Department, HUJI, Jerusalem

  – Technion Medical School 

  – UC, Berkeley’s Genomics Institute 

  – UC, Berkeley’s Public Health Department or 

  – UCSF

  – Stanford Medicine Institutes

  3. Finding for-profit potential acquirers: I.e., 

  – Wolfram Kruwel, owner of UpToDate, 

  – KKR, holding company of WebMD

  – eScientific Publishers: John Wiley, Pearson or Internationals in Japan, Germany, 

 

• SYNOPSIS – 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM

https://pharmaceuticalintelligence.com/2018/06/14/17th-annual-summer-symposium-breakthrough-cancer-nanotechnologies-koch-institute-mit-kresge-auditorium-june-15-2018-9am-4pm-2/

 

• Original Tweets Re-Tweets and Likes by @pharma_BI and @AVIVA1950 at #kisymposium for 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM

https://pharmaceuticalintelligence.com/2018/06/17/original-tweets-re-tweets-and-likes-by-pharma_bi-and-aviva1950-at-kisymposium-for-17th-annual-summer-symposium-breakthrough-cancer-nanotechnologies-koch-institute-mit-kresge-auditorium-june-15/

 

• Survival Calls during Careers in the Digital Age

https://pharmaceuticalintelligence.com/2018/06/13/survival-calls-during-careers-in-the-digital-age/

 

• Reactions to Original Tweets by @Pharma_BI and by @AVIVA1950 from #BIO2018

https://pharmaceuticalintelligence.com/2018/06/12/reactions-to-original-tweets-by-pharma_bi-and-by-aviva1950-from-bio2018/

 

• Re-Tweets and Likes by @Pharma_BI and by @AVIVA1950 from #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

https://pharmaceuticalintelligence.com/2018/06/11/re-tweets-and-likes-by-pharma_bi-aviva1950-from-bio2018-iambiotech-bioconvention-bio-2018-boston-june-4-7-2018-bcec/

 

• Original Tweets by @Pharma_BI and by @AVIVA1950 from #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

https://pharmaceuticalintelligence.com/2018/06/11/original-tweets-by-pharma_bi-and-by-aviva1950-from-bio2018-iambiotech-bioconvention-bio-2018-boston-june-4-7-2018-bcec/

 

• Thriving at the Survival Calls during Careers in the Digital Age – An AGE like Other, also known as, DIGITAL

https://pharmaceuticalintelligence.com/2018/06/11/thriving-at-the-survival-calls-during-careers-in-the-digital-age-an-age-like-no-other-also-known-as-digital/

 

• Reflections on a Four-phase Career: Aviva Lev-Ari, PhD, RN, March 2018

https://pharmaceuticalintelligence.com/2018/03/06/reflections-on-a-four-phase-career-aviva-lev-ari-phd-rn-march-2018/

 

• Pioneering implementations of analytics to business decision making: contributions to domain knowledge conceptualization, research design, methodology development, data modeling and statistical data analysis: Aviva Lev-Ari, UCB, PhD’83; HUJI MA’76

https://pharmaceuticalintelligence.com/2018/05/28/pioneering-implementations-of-analytics-to-business-decision-making-contributions-to-domain-knowledge-conceptualization-research-design-methodology-development-data-modeling-and-statistical-data-a/

 

• Recollections: Part 1 – My days at Berkeley, 9/1978 – 12/1983 – About my doctoral advisor, Allan Pred, other Professors and other Peers

https://pharmaceuticalintelligence.com/2018/03/15/recollections-my-days-at-berkeley-9-1978-12-1983-about-my-doctoral-advisor-allan-pred-other-professors-and-other-peer/

 

• Recollections: Part 2 – “While Rolling” is preceded by “While Enrolling” Autobiographical Alumna Recollections of Berkeley – Aviva Lev-Ari, PhD’83

https://pharmaceuticalintelligence.com/2018/05/24/recollections-part-2-while-rolling-is-preceded-by-while-enrolling-autobiographical-alumna-recollections-of-berkeley-aviva-lev-ari-phd83/

 

• Professional Self Re-Invention: From Academia to Industry – Opportunities for PhDs in the Business Sector of the Economy

https://pharmaceuticalintelligence.com/2018/05/22/professional-self-re-invention-from-academia-to-industry-opportunities-for-phds-in-the-business-sector-of-the-economy/

 

• Key Opinion Leader (KOL) in Pharmaceutical Business Intelligence – Aviva Lev-Ari, PhD, RN, as evidenced by

https://pharmaceuticalintelligence.com/2016/07/21/key-opinion-leader-kol-aviva-lev-ari-phd-rn-as-evidenced-by/

 

• Data Science is the Greatest Science! It is the Greatest Science for Women, as well

https://pharmaceuticalintelligence.com/2018/03/12/data-science-is-the-greatest-science-it-is-the-greatest-science-for-women-as-well/

 

About the Open Access Online Scientific Journal pharmaceuticalintelligence.com

 

• Electronic Scientific AGORA: Comment Exchanges by Global Scientists on Articles published in the Open Access Journal @pharmaceuticalintelligence.com – Four Case Studies

 

• e-Scientific Publishing: The Competitive Advantage of a Powerhouse for Curation of Scientific Findings and Methodology Development for e-Scientific Publishing – LPBI Group, A Case in Point – Updated on 4/2/2018

 

 

List of BioTech Conferences in 2018

covered in REAL TIME by Aviva Lev-Ari, PhD, RN

 

2018 MassBio Annual Meeting March 21, 2017 8:00 AM – March 22, 2017 4:00 PM, Royal Sonesta Boston, Cambridge MA – Due to Snow Storm Warning I did not attend.

https://pharmaceuticalintelligence.com/2018/02/06/2018-massbio-annual-meeting-march-21-2017-800-am-march-22-2017-400-pm-royal-sonesta-boston-cambridge-ma/

 

AI & Machine Learning in Clinical Trials, APRIL 12, 2018 PFIZER INNOVATION RESEARCH LAB – CAMBRIDGE, MA

https://pharmaceuticalintelligence.com/2018/04/02/ai-machine-learning-in-clinical-trials-april-12-2018-pfizer-innovation-research-lab-cambridge-ma/

 

2018 Annual World Medical Innovation Forum Artificial Intelligence April 23–25, 2018 Boston, Massachusetts  |  Westin Copley Place

https://pharmaceuticalintelligence.com/2018/01/18/2018-annual-world-medical-innovation-forum-artificial-intelligence-april-23-25-2018-boston-massachusetts-westin-copley-place/

 

The Convergence of Medical Devices & Drugs: Advances in Drug Delivery May 3, 2018 12:00 PM – 5:00 PM, Westin Hotel, Waltham, MA

https://pharmaceuticalintelligence.com/2018/04/05/the-convergence-of-medical-devices-drugs-advances-in-drug-delivery-may-3-2018-1200-pm-500-pm-westin-hotel-waltham-ma/

 

12th Annual US-India BioPharma & Healthcare Summit, May 8, 2018, Marriott Cambridge

https://pharmaceuticalintelligence.com/2018/01/18/12th-annual-us-india-biopharma-healthcare-summit-may-8-2018-marriott-cambridge/

 

2018 CHI’s BioIT World conference & Expo, May 15 – 17, 2018, Boston, MA – Seaport World Trade Center

https://pharmaceuticalintelligence.com/2018/04/05/2018-chis-bioit-world-conference-expo-may-15-17-2018-boston-ma-seaport-world-trade-center/

 

BIO 2018! June 4-7, 2018 at Boston Convention & Exhibition Center 

https://pharmaceuticalintelligence.com/2018/05/26/bio-2018-june-4-7-2018-at-boston-convention-exhibition-center/

 

 

CHI’s Discovery on Target, Sheraton Boston, Sept. 25-28, 2018

https://pharmaceuticalintelligence.com/2018/02/21/chis-discovery-on-target-sheraton-boston-sept-25-28-2018/

 

The 14th Annual Personalized Medicine Conference, November 13 – 15, 2018, Joseph B. Martin Conference Center, HARVARD MEDICAL SCHOOL, Boston

http://www.personalizedmedicinecoalition.org/Events

 

List of BioTech Conferences in 2013 – 2018

covered in REAL TIME by Aviva Lev-Ari, PhD, RN on Press Pass

Year	# Conferences covered in Real Time	Conference Organizers
2020
2019
2018	10	MassBio, AI,ML&CL, MassBio-Devices&Drugs, WMIF-AI-Partners, US-India BioPharma, BioIT, BIO 2018!, Koch@MIT, , CHI-DiscoveryonTarget, PMC-HMS
2017	12	MassBio, WMIF-CVD-Partners, US-India BioPharma, BioIT, Koch@MIT, CHI-IO CHI OncoVirus IO, WarrenLecture-HMS, HubWeek, Koch@MIT, EmTech@MIT, PMC-HMS
2016	8	MassBio, WMIF-Cancer-Partners, US-IndiaBioPharma, CHI-IO, CHI-OncoVirus IO, CHI DiscoveryonTarget, EmTech @MIT, PMC-HMS
2015	5	PMWC-SiliconVallley, MassBio, BioIT, EmTech@MIT, PMC-HMS,
2014	7	SacksAssoc-NY, MassBio, BioIT Koch@MIT, SacksAssoc-Basel, Brandeis, PMC-HMS,
2013	1	BioIT

 

• Tweets Impression Analytics, Re-Tweets, Tweets and Likes by @AVIVA1950 and @pharma_BI for 2018 BioIT, Boston, 5/15 – 5/17, 2018
• 12th Annual US-India BioPharma & Healthcare Summit, May 8, 2018, Marriott Cambridge

 

• Retweets, Likes of Tweets by @AVIVA1950 @pharma_BI on May 8, 2018 for 12th Annual US-India BioPharma & Healthcare Summit, May 8, 2018, Marriott,  Cambridge @USAIC #USAIC2018

 

• 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM

 

• Retweets, Likes of Tweets by @AVIVA1950 on 4/23/2018 – 4/25/2018 at 2018 Annual World Medical Innovation Forum Artificial Intelligence April 23–25, 2018 Boston, Massachusetts  | Westin 

 

• Synopsis Days 1,2,3: 2018 Annual World Medical Innovation Forum Artificial Intelligence April 23–25, 2018 Boston, Massachusetts  | Westin Copley Place

 

• Synopsis Day 1: 2018 Annual World Medical Innovation Forum Artificial Intelligence April 23–25, 2018 Boston, Massachusetts  | Westin Copley Place

https://pharmaceuticalintelligence.com/2018/04/23/synopsis-day-1-2018-annual-world-medical-innovation-forum-artificial-intelligence-april-23-25-2018-boston-massachusetts-westin-copley-place/

• Synopsis Day 2: 2018 Annual World Medical Innovation Forum Artificial Intelligence April 23–25, 2018 Boston, Massachusetts  | Westin Copley Place

https://pharmaceuticalintelligence.com/2018/04/24/https-pharmaceuticalintelligence-wordpress-com-p47489previewtruesynopsis-day-2-2018-annual-world-medical-innovation-forum-artificial-intelligence-april-23-25-2018-boston-massachus/

• Synopsis Day 3: 2018 Annual World Medical Innovation Forum Artificial Intelligence April 23–25, 2018 Boston, Massachusetts  | Westin Copley Place

https://pharmaceuticalintelligence.com/2018/04/25/synopsis-day-3-2018-annual-world-medical-innovation-forum-artificial-intelligence-april-23-25-2018-boston-massachusetts-westin-copley-place/

 

• Synopsis for AI & Machine Learning in Clinical Trials, APRIL 12, 2018 PFIZER INNOVATION RESEARCH LAB – CAMBRIDGE, MA

https://pharmaceuticalintelligence.com/2018/04/02/ai-machine-learning-in-clinical-trials-april-12-2018-pfizer-innovation-research-lab-cambridge-ma/

• Tweets for AI and Machine Learning in Clinical Trials April 12th, 2018 hosted at Pfizer’s Innovation Research Lab in Cambridge, MA @AVIVA1950 @pharma_BI

https://pharmaceuticalintelligence.com/2018/04/12/tweets-for-ai-and-machine-learning-in-clinical-trials-april-12th-2018-hosted-at-pfizers-innovation-research-lab-in-cambridge-ma-aviva1950-pharma_bi/

 

 

3/31/2018

Aviva Lev-Ari, PhD, RN was nominated for the 2018 XXXXXX Prize for contributions to YYYYYYY Development 

 

List of Conferences to be attended and covered in Real Time in 2018, includes the following Conferences:

• AI & Machine Learning in Clinical Trials, APRIL 12, 2018 PFIZER INNOVATION RESEARCH LAB – CAMBRIDGE, MA

https://pharmaceuticalintelligence.com/2018/04/02/ai-machine-learning-in-clinical-trials-april-12-2018-pfizer-innovation-research-lab-cambridge-ma/

 

• 2018 Annual World Medical Innovation Forum Artificial Intelligence April 23–25, 2018 Boston, Massachusetts  |  Westin Copley Place

https://pharmaceuticalintelligence.com/2018/01/18/2018-annual-world-medical-innovation-forum-artificial-intelligence-april-23-25-2018-boston-massachusetts-westin-copley-place/

 

• The Convergence of Medical Devices & Drugs: Advances in Drug Delivery May 3, 2018 12:00 PM – 5:00 PM, Westin Hotel, Waltham, MA

https://pharmaceuticalintelligence.com/2018/04/05/the-convergence-of-medical-devices-drugs-advances-in-drug-delivery-may-3-2018-1200-pm-500-pm-westin-hotel-waltham-ma/

 

• 12th Annual US-India BioPharma & Healthcare Summit, May 8, 2018, Marriott Cambridge

https://pharmaceuticalintelligence.com/2018/01/18/12th-annual-us-india-biopharma-healthcare-summit-may-8-2018-marriott-cambridge/

 

• 2018 CHI’s BioIT World conference & Expo, May 15 – 17, 2018, Boston, MA – Seaport World Trade Center

https://pharmaceuticalintelligence.com/2018/04/05/2018-chis-bioit-world-conference-expo-may-15-17-2018-boston-ma-seaport-world-trade-center/

 

• CHI’s Discovery on Target, Sheraton Boston, Sept. 25-28, 2018

https://pharmaceuticalintelligence.com/2018/02/21/chis-discovery-on-target-sheraton-boston-sept-25-28-2018/

 

• The 14th Annual Personalized Medicine Conference, November 13 – 15, 2018, Joseph B. Martin Conference Center, HARVARD MEDICAL SCHOOL, Boston

http://www.personalizedmedicinecoalition.org/Events

 

2017

12/30/2017

 

Volume Four:  Medical 3D BioPrinting – The Revolution in Medicine, Technologies for Patient-centered Medicine: From R&D in Biologics to New Medical Devices 

Editors: Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN

Available on Kindle Store @ Amazon.com since 12/30/2017

https://www.amazon.com/dp/B078QVDV2W

List of Contributors

Larry H. Bernstein, MD, FCAP

1.1, 1.2, 1.3, 1.4, 1.5, 1.7, 1.9, 2.3, 3.3, 3.10, 4.1, 4.2, 4.3, 4.8, 5.4, 7.1, 7.2, 7.3, 7.4, 7.5, 7.9, 7.10, 8.1, 8.2, 8.5, 9.1, 12.1, 12.2, 12.3, 12.8, 13.6

Aviva Lev-Ari, PhD, RN

1.8, 1.14, 2.1, 2.2, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 2.10, 2.11, 3.1, 3.2, 3.4, 3.6, 3.7, 3.8, 3.9, 3.10, 4.10, 4.17, 5.2, 5.3, 6.3, 6.4, 6.5, 6.6, 6.11, 7.1, 7.6, 7.7, 8.2, 9.2, 9.3, 9.4, 9.6, 10.1, 10.2, 10.3, 11.4, 11.5, 12.5, 13.1, 13.4, 13.7

Irina Robu, PhD

1.6, 1.12, 1.12.1, 1.12.2, 1.13.1, 1.15, 1.16, 4.4, 4.4.1, 4.5, 4.6, 4.9.1, 4.11, 4.12, 4.14, 4.14.1, 4.15, 4.16, 5.1, 5.5, 6.9, 6.12, 6.13, 7.8, 8.3, 8.4, 9.7, 9.8, 10.4, 12.1.1, 12.1.2, 12.4, 12.8.1, 12.8.2, 12.8.3, 12.9, 12.10, 13.3, 13.5

Stephen J. Williams, PhD

1.10, 6.1, 6.2, 6.7, 6.10, 12.7, 13.2

Danut Dragoi, PhD

1.11, 4.7, 4.9, 6.8, 9.5, 10.5, 11.1, 11.6

Tilda Barliya, PhD

1.13

Justin Pearlman MD PhD

3.5, 4.13

Gerard Loiseau, ESQ

5.2, 9.3, 11.3

Stuart Cantor, PhD

11.2

Evelina Cohn, PhD

12.6

Gail S. Thornton, M.A., PhD(c)

4.18, 4.19

12/20/2017

LPBI Group Accomplishments 4/2012 – 12/2017 for Open Access Online Scientific Journal
http://pharmaceuticalintelligence.com

1,354,866 e-Readers

7,282 Scientific Comments

5,231 Scientific Articles,

610 Research Categories in Medicine and Life Sciences

9,719 Tags

2,284 Subscribers

Accomplishments 4/2012 – 12/2017 for BioMed e-Series
https://pharmaceuticalintelligence.com/biomed-e-books/

electronic Table of Contents (eTOCs) of each Volume in the SIXTEEN Volume BioMed e-Series
https://pharmaceuticalintelligence.com/2017/12/12/biomed-e-series-16-volumes-electronic-table-of-contents-of-each-volume/

WE ARE ON AMAZON.COM
https://www.amazon.com/s/ref=nb_sb_noss?url=search-alias%3Ddigital-text&field-keywords=Aviva+Lev-Ari&rh=n%3A133140011%2Ck%3AAviva+Lev-Ari

https://www.amazon.com/s/ref=dp_byline_sr_ebooks_9?ie=UTF8&text=Aviva+Lev-Ari&search-alias=digital-text&field-author=Aviva+Lev-Ari&sort=relevancerank

http://www.amazon.com/dp/B00DINFFYC
http://www.amazon.com/dp/B018Q5MCN8
http://www.amazon.com/dp/B018PNHJ84
http://www.amazon.com/dp/B018DHBUO6
http://www.amazon.com/dp/B013RVYR2K
http://www.amazon.com/dp/B012BB0ZF0
http://www.amazon.com/dp/B019UM909A
http://www.amazon.com/dp/B019VH97LU
http://www.amazon.com/dp/B071VQ6YYK
https://www.amazon.com/dp/B075CXHY1B
https://www.amazon.com/dp/B076HGB6MZ
https://www.amazon.com/dp/B078313281

11/17/2017

• Tweets by @pharma_BI and @AVIVA1950 for #PMConf at The 13th Annual Personalized Medicine Conference, From Concept to the Clinic, November 14–16, 2017, Joseph B. Martin Conference Center, Harvard Medical School

https://pharmaceuticalintelligence.com/2017/11/17/tweets-by-pharma_bi-and-aviva1950-for-pmconf-at-the-13th-annual-personalized-medicine-annual-meeting-from-concept-to-the-clinic-november-14-16-20/

 

• Day 1 – 13th Annual Personalized Medicine Conference, From Concept to the Clinic, November 14–16, 2017

https://pharmaceuticalintelligence.com/2017/11/15/live-day-one-13th-annual-personalized-medicine-from-concept-to-the-clinic-november-14-16-2017-joseph-b-martin-conference-center-harvard-medical-school-77-avenue-louis-pasteur-bos/

 

• Day 2 – 13th Annual Personalized Medicine Conference, From Concept to the Clinic, November 14–16, 2017

https://pharmaceuticalintelligence.com/2017/11/16/live-day-two-13th-annual-personalized-medicine-from-concept-to-the-clinic-november-14-16-2017-joseph-b-martin-conference-center-harvard-medical-school-77-avenue-louis-pasteur-bos/

11/9/2017

Mr. Sweeney,

Thank you for having me as MEDIA on this OUTSTANDING event – 2017 EmTechMIT

• LIVE Day Two and Day One – 17th Annual EmTech @ Media Lab, MIT – November 7 – 8, 2017, Cambridge, MA – This Year’s Themes, Speakers and Agenda

https://pharmaceuticalintelligence.com/2017/09/08/17th-annual-emtech-media-lab-mit-november-7-8-2017-cambridge-ma-this-years-themes-speakers-and-agenda/

• All my Tweets for 11/7 and 11/8 at @AVIVA1950
• #EmTechMIT – only some are featured , not all – Why?
• All my Tweets for 11/7 and 11/8 at @pharma_BI

Kind regards,

Aviva Lev-Ari, PhD, RN

Director & Founder

Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston

Editor-in-Chief

http://pharmaceuticalintelligence.com

e-Mail: avivalev-ari@alum.berkeley.edu

https://cal.berkeley.edu/AvivaLev-Ari,PhD,RN

SkypeID: HarpPlayer83          LinkedIn Profile        Twitter Profile

 

10/24/2017

Koch Institute Immune Engineering Symposium on October 16 & 17, 2017, Kresge, MIT

https://pharmaceuticalintelligence.com/2017/09/08/koch-institute-immune-engineering-symposium-on-october-16-17-2017-kresge-mit/

 

LIVE HubWeek – Harvard, MIT, MGH, Boston multiple locations, 10/10 – 10/15, 2017

https://pharmaceuticalintelligence.com/2017/09/23/hubweek-harvard-mit-mgh-boston-multiple-locations-1012-1015-2017/

 

Lectures by The 2017 Award Recipients of Warren Alpert Foundation Prize in Cancer Immunology, October 5, 2017, HMS, 77 Louis Paster, Boston

https://pharmaceuticalintelligence.com/2017/09/08/lectures-by-the-2017-award-recipients-of-warren-alpert-foundation-prize-in-cancer-immunology-october-5-2017-hms-77-louis-paster-boston/

 

10/16/2017

Series E: Patient-centered Medicine

Content Consultant: Larry H Bernstein, MD, FCAP

Volume 1: The VOICES of Patients, Hospitals CEOs, Health Care Providers, Caregivers and Families: Personal Experience with Critical Care and Invasive Medical Procedures

Author, Curator and Editor: Larry H Bernstein, MD, FCAP and Gail Thornston, PhD(c)

On Amazon.com since 10/16/2017

https://www.amazon.com/dp/B076HGB6MZ

 

9/8/2017

List of LIVE Press Coverage of BioTech Conferences in 2017

The 13th Annual Personalized Medicine Conference, NOVEMBER 14 – 16, 2017, Joseph B. Martin Conference Center, HARVARD MEDICAL SCHOOL, Boston

https://pharmaceuticalintelligence.com/2017/03/13/the-13th-annual-personalized-medicine-conference-from-concept-to-the-clinic-november-14-16-2017-joseph-b-martin-conference-center-harvard-medical-school-77-avenue-louis-pasteur-boston/

 

17th Annual EmTech @ Media Lab, MIT – November 7 – 8, 2017, Cambridge, MA – This Year’s Themes, Speakers and Agenda

https://pharmaceuticalintelligence.com/2017/09/08/17th-annual-emtech-media-lab-mit-november-7-8-2017-cambridge-ma-this-years-themes-speakers-and-agenda/

 

Koch Institute Immune Engineering Symposium on October 16 & 17, 2017, Kresge, MIT

https://pharmaceuticalintelligence.com/2017/09/08/koch-institute-immune-engineering-symposium-on-october-16-17-2017-kresge-mit/

 

Lectures by The 2017 Award Recipients of Warren Alpert Foundation Prize in Cancer Immunology, October 5, 2017, HMS, 77 Louis Paster, Boston

https://pharmaceuticalintelligence.com/2017/09/08/lectures-by-the-2017-award-recipients-of-warren-alpert-foundation-prize-in-cancer-immunology-october-5-2017-hms-77-louis-paster-boston/

 

CHI’s Oncolytic Virus Immunotherapy and ADOPTIVE CELL THERAPY, August 28-29, 2017 Sheraton Boston Hotel | Boston, MA

https://pharmaceuticalintelligence.com/2017/08/29/live-829-chis-oncolytic-virus-immunotherapy-and-adoptive-cell-therapy-august-28-29-2017-sheraton-boston-hotel-boston-ma/

 

CHI’s 5th Immune Oncology Summit – CHI’s 4th Oncolytic Virus Immunotherapy, August 28-29, 2017 Sheraton Boston Hotel | Boston, MA

https://pharmaceuticalintelligence.com/2017/08/28/live-828-chis-5th-immune-oncology-summit-oncolytic-virus-immunotherapy-august-28-29-2017-sheraton-boston-hotel-boston-ma/

 

16th Annual Cancer Research Symposium, Koch Institute, Friday, June 16, 2017, 9AM – 5PM, Kresge Auditorium, MIT

https://pharmaceuticalintelligence.com/2017/03/13/16th-annual-cancer-research-symposium-koch-institute-friday-june-16-9am-5pm-kresge-auditorium-mit/

 

BioInformatics: Track 6: BioIT World Conference & Expo ’17, May 23-25, 2017, Seaport World Trade Center, Boston, MA – On an Unplanned Overseas Trip

https://pharmaceuticalintelligence.com/2017/01/12/2017-agenda-bioinformatics-track-6-bioit-world-conference-expo-17-may-23-35-2017-seaport-world-trade-center-boston-ma/

 

11th US-India BioPharma & Healthcare Summit, Thursday, May 18, 2017, Boston Marriott Cambridge, 50 Broadway, Cambridge

https://pharmaceuticalintelligence.com/2017/05/18/live-11th-us-india-biopharma-healthcare-summit-thursday-may-18-2017-boston-marriott-cambridge-50-broadway-cambridge/

 

2017 World Medical Innovation Forum: Cardiovascular, May 1-3, 2017, Partners HealthCare, Boston, at the Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2016/12/14/2017-world-medical-innovation-forum-cardiovascular-may-1-3-2017-partners-healthcare-boston-at-the-westin-hotel-boston/

 

2017 MassBio Annual Meeting March 30, 2017 8:00 AM – March 31, 2017 4:00 PM, Royal Sonesta Boston, Cambridge MA

https://pharmaceuticalintelligence.com/2017/02/28/2017-massbio-annual-meeting-march-30-2017-800-am-march-31-2017-400-pm-royal-sonesta-boston-cambridge-ma/

 

9/6/2017

MON, September 4, 2017 we published on Amazon.com

The Immune System, Stress Signaling, Infectious Diseases and Therapeutic Implications: VOLUME 2: Infectious Diseases and Therapeutics and VOLUME 3: The Immune System and Therapeutics (Series D: BioMedicine & Immunology) Kindle Edition

by Larry H. Bernstein (Author), Aviva Lev-Ari (Author), Stephen J. Williams (Author), Demet Sag (Author), Irina Robu (Author), Tilda Barliya (Author), David Orchard-Webb (Author), Alan F. Kaul (Author), Danut Dragoi (Author), Sudipta Saha (Editor)

https://www.amazon.com/dp/B075CXHY1B

 

MON, June 2017 – Aviva presented to Number 1 in the Scientific Publishing Corporation

Resources used included the following:

e-Scientific Publishing: The Competitive Advantage of a Powerhouse for Curation of Scientific Findings and Methodology Development for e-Scientific Publishing – LPBI Group, A Case in Point

FIVE years of e-Scientific Publishing @pharmaceuticalintellicence.com, Top Articles by Author and by e-Views >1,000, 4/27/2012 to 4/27/2017

Innovations in electronic Scientific Publishing (eSP): Case Studies in Marketing eContent, Curation Methodology, Categories of Research Functions, Interdisciplinary conceptual innovations by Cross Section of Categories, Exposure to Frontiers of Science by Real Time Press coverage of Scientific Conferences

Editorial & Publication of Articles in e-Books by Leaders in Pharmaceutical Business Intelligence: Contributions of Larry H Bernstein, MD, FCAP

Editorial & Publication of Articles in e-Books by Leaders in Pharmaceutical Business Intelligence: Contributions of Aviva Lev-Ari, PhD, RN

5/18/2017

OUR NEW CANCER e-Book on Amazon.com

Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery (Series C Book 2) – Kindle edition, on Amazon since 5/18/2017

Our 9th e-Book on CANCER, 2800 pages – is LIVE on Amazon.com – first day, 5/18/2017

https://www.amazon.com/dp/B071VQ6YYK

See all ours other 8 e-Books in Medicine on Amazon.com

WE ARE ON AMAZON.COM

https://www.amazon.com/s/ref=dp_byline_sr_ebooks_9?ie=UTF8&text=Aviva+Lev-Ari&search-alias=digital-text&field-author=Aviva+Lev-Ari&sort=relevancerank

5/5/2017

• World Medical Innovation Forum – CARDIOVASCULAR • MAY 1-3, 2017, BOSTON, MA

(a) Real Time Highlights and Tweets: Day 1,2,3: World Medical Innovation Forum – CARDIOVASCULAR • MAY 1-3, 2017, BOSTON, MA

• https://pharmaceuticalintelligence.com/2017/05/03/deliverables-day-123-world-medical-innovation-forum-cardiovascular-%E2%80%A2-may-1-3-2017-boston-ma-httpsworldmedicalinnovation-orgagenda-highlights-of-live-day-1-world-medical/

(b) e-Proceedings for Day 1,2,3: World Medical Innovation Forum – CARDIOVASCULAR • MAY 1-3, 2017, BOSTON, MA

• https://pharmaceuticalintelligence.com/2017/05/05/e-proceedings-for-day-123-world-medical-innovation-forum-cardiovascular-%E2%80%A2-may-1-3-2017-boston-ma/

(c)  Tweets by @pharma_BI and @AVIVA1950 at World Medical Innovation Forum – CARDIOVASCULAR • MAY 1-3, 2017, BOSTON, MA

• https://pharmaceuticalintelligence.com/2017/05/05/tweets-by-pharma_bi-and-aviva1950-at-world-medical-innovation-forum-cardiovascular-%E2%80%A2-may-1-3-2017-boston-ma/

4/1/2017

e-Books in Medicine

1. Larry Mulligan, PhD has joined LPBI Group as Co-Editor for Series A, Volume 5 [may be Volume 6??]
2. Dr. Justin Pearlman, MD, PhD is working as Editor for a FOUR Volume Hard Copy Series in Cardiology
3. Gail Thornton, MSc,  PhD(c), Co-Editor for Series E, Volume 1 – is bringing to completion this volume
4. Marzan Khan, BSc, Research Associate and Translator for Series E, Volume 2 – is in midst of volume Format conversion [may be Series e, Volume 4??]
5. Tilda Barlyia, PhD, Senior Editor of Series C, Cancer, Volume 2 – completed proof reading the entire 3,000 page Volume following Format conversion by Kelly Perlman. This volume is scheduled for upload to Amazon.com on the first week in April 2017.
6. Seeking Co-Editor for Genomics, Volume Two
7. Series D: Biomedicine:

VOLUME 1,

• Metabolic Genomics and Pharmaceutics, on Amazon since 7/21/2015

http://www.amazon.com/dp/B012BB0ZF0

VOLUME 2,

• Infectious Diseases and Therapeutics

Author, Curator and Editor: Sudipta Saha, PhD

VOLUME 3,

• The Immune System and Therapeutics

Author, Curator and Editor: Larry H Bernstein, MD, FCAP

 

3/13/2017

List of BioTech Conferences we cover in Real Time in 2017

The 13th Annual Personalized Medicine Conference, NOVEMBER 14 – 16, 2017, Joseph B. Martin Conference Center, HARVARD MEDICAL SCHOOL, Boston

https://pharmaceuticalintelligence.com/2017/03/13/the-13th-annual-personalized-medicine-conference-from-concept-to-the-clinic-november-14-16-2017-joseph-b-martin-conference-center-harvard-medical-school-77-avenue-louis-pasteur-boston/

16th Annual Cancer Research Symposium, Koch Institute, Friday, June 16, 2017, 9AM – 5PM, Kresge Auditorium, MIT

https://pharmaceuticalintelligence.com/2017/03/13/16th-annual-cancer-research-symposium-koch-institute-friday-june-16-9am-5pm-kresge-auditorium-mit/

BioInformatics: Track 6: BioIT World Conference & Expo ’17, May 23-25, 2017, Seaport World Trade Center, Boston, MA

https://pharmaceuticalintelligence.com/2017/01/12/2017-agenda-bioinformatics-track-6-bioit-world-conference-expo-17-may-23-35-2017-seaport-world-trade-center-boston-ma/

2017 World Medical Innovation Forum: Cardiovascular, May 1-3, 2017, Partners HealthCare, Boston, at the Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2016/12/14/2017-world-medical-innovation-forum-cardiovascular-may-1-3-2017-partners-healthcare-boston-at-the-westin-hotel-boston/

2017 MassBio Annual Meeting March 30, 2017 8:00 AM – March 31, 2017 4:00 PM, Royal Sonesta Boston, Cambridge MA

https://pharmaceuticalintelligence.com/2017/02/28/2017-massbio-annual-meeting-march-30-2017-800-am-march-31-2017-400-pm-royal-sonesta-boston-cambridge-ma/

 

1/23/2017

e-Books in Medicine

1. Larry Mulligan, PhD has joined LPBI Group as Co-Editor for Series A, Volume 5 [may be Volume 6??]
2. Dr. Justin Pearlman, MD, PhD is working as Editor for a FOUR Volume Hard Copy Series in Cardiology
3. Gail Thornton, MSc,  PhD(c), Co-Editor for Series E, Volume 1 – is bringing to completion this volume
4. Marzan Khan, BSc, Research Associate and Translator for Series E, Volume 2 – is in midst of volume Format conversion [may be Series e, Volume 4??]
5. Tilda Barlyia, PhD, Senior Editor of Series C, Cancer, Volume 2 – is proof reading the entire 3,000 page Volume following Format conversion by Kelly Perlman
6. Seeking Co-Editor for Genomics Volume 2

DrugDiscovery & DrugDelivery @LPBI Group

• Our Team – DrugDiscovery @LPBI Group, is developing a new Mechanism of Action for Panceatic Cancer and Several other Cancers honing hybrid exosome-lysosome technology for an Oncolytic Viral Therapeutics solution

Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/contributors-biographies/aviva-lev-ari/

Dr. Raphael Nir – Drug Discovery: Expertise in Cancer

https://pharmaceuticalintelligence.com/contributors-biographies/experts-authors-writers-eaws/raphael-nir-phd-msm-msc/

Dr. David Orchard-Webb – Drug Discovery: Expertise in Pancreatic Cancer

https://pharmaceuticalintelligence.com/contributors-biographies/experts-authors-writers-eaws/david-orchard-webb-phd-mts-scientist-ii-drugdiscovery-lpbi-group-cancer-indication 

Dr. Irina Robu – Drug Delivery – Expertise in Nanotechnology, Polymers, Hybridization: Liposome, Exosome, Lysosome

https://pharmaceuticalintelligence.com/contributors-biographies/business-development-private-equity-investment/irina-s-robu-phd-material-scientist-and-business-developer-for-materials-segment-of-manufacturing-industry/

Dr. Aashir Awan – Drug Discovery: Expertise in Salivary Adenoid Cystic Carcinoma and cilia: motile cilia and nonmotile, or primary cilia, which typically serve as sensory organelles, In vivo and In vitro wet lab studies

https://pharmaceuticalintelligence.com/contributors-biographies/experts-authors-writers-eaws/aashir-awan-phd-expert-author-writer/

Dr. Tilda Barlyia – Scientific Consultant to Aviva and to Our Team: DrugDiscovery @LPBI Group

Expertise in Molecular Biology, Cancer, Nanotechnology, Ophthalmology

https://pharmaceuticalintelligence.com/contributors-biographies/senior-editors/tilda-barliya-phd-expert-author-writer-research-category-owner-nanotechnology-for-drug-delivery/

Ms. Marzan Khan – Lab Biochemistry and Physics

https://pharmaceuticalintelligence.com/contributors-biographies/associates/marzan-khan-bsc-research-associate-lpbi-groups-biomed-e-series-published-on-amazon-com/

 

Funding Early Stage Start Ups

a. We will continue to develop the concepts of mutual interest between

• A company on the West Coast
• Dr. Nir of ABI-LAB, SBH Sciences, Inc., SBH Diagnostics, Inc.

and

• Our Team – DrugDiscovery @LPBI Group:

b.  Aviva, Alpha Senzsor, Inc. and an Investor are exploring two industries in France

c.  Aviva and WJ, an Investor are exploring opportunities in the US, UK

d. Aviva and Arie Berger and Maggie You are exploring opportunities in China

 

1/7/2017

OPPORTUNITIES for Business Development EXEC – BioTech, Medical Devices, Publishing – CONTACT: avivalev-ari@alum.berkeley.edu

— BD to Sell the e-Scientific Journal to a European or Japanese Scientific Publisher
— BD to Sell the BioMed e-Series of 15 e-Books in Medicine to a European or Japanese Scientific Publisher
— BD to Sell the Methodology to a European or Japanese International Biotech Conference Organizer.
— BD to develop markets for several US Patent Holder for Licensing and Commercialize the technologies: Biologics and Medical Devices Patents
— BD to develop a Market for an e-Book on 3D BioPrinting
— BD to PROSPECT for FUNDING or M&A with existing Biotech in Biologics: Drug Discovery
— BD to develop FUNDING for 13 Ventures in Early Stage Biotech Start Ups: MEDICAL DEVICES & Biologics

 

2016

12/26/2016

Year End 2016 Statement on Yearly Progress by LPBI Group

Curator: Aviva Lev-Ari, PhD, RN

LPBI Group has Three Enterprise Types and Five Subsidiaries as described, below.

 Image Source: Google Images

We are in Knowledge-based Informational Services

Line-of-Business #1:

Open Access OnLine Scientific Journal  

• 1,121,301 e-Readers, Site Statistics on 12/26/2016 

June 19, 2016 – We Celebrate reaching over One Million e-Readers @PharmaceuticalIntelligence.com

Editor-in-Chief: Aviva Lev-Ari, PhD, RN

• 5,005 Scientific Articles, Site Statistics on 12/26/2016 

We Celebrate 5,000 Scientific Articles @pharmaceuticalintelligence.com – 2016 was a GREAT Year !!!!!

Curator and Open Access Journal Editor-in-Chief: Aviva Lev-Ari, PhD, RN

• Top Authors for All Days ending 2016-12-01: GROWTH Trends @Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Curator: Aviva Lev-Ari, PhD, RN

• 7,267 Comments by Scientists, Site Statistics on 12/26/2016 
• 2,183 Subscribers, Site Statistics on 12/26/2016

 

Line-of-Business #2:

BioMed e-Series, Five Series in Medicine, 8 e-Books on Amazon.com, 7 e-Books in 2017

• New e-Book TITLES forthcoming on Amazon.com in 2016 from LPBI Group’s BioMed e-Series –Forthcoming COVER PAGES

Editor-in-Chief, Aviva Lev-Ari, PhD, RN

 

Line-of-Business #3:

Real Time Press Coverage of BioTech Global Premier Conferences, Portfolio of ~30 events

• Super RECORD of REAL TIME Coverage of Biotech and Medicine Conferences by LPBI Group in 2016

Curator: Aviva Lev-Ari, PhD, RN

Line-of-Business #4: No Progress in 2016

Audio-Podcast Series in Medicine, 5 tracks

&

• Subsidiary 4: Intellectual Property Asset Management

Line-of-Business #5: New Patents issued to Bill Zurn

Representation of US Patent Holders for Commercialization, Licensing and Partnerships

We are in Research Biotech Businesses

 

• Subsidiary 3: R&D in 3D BioPrinting

Line-of-Business #6:

Tissue Engineering, Gene Therapy: Stem Cells & Gene Editing, Medical Devices: Product Concepts

• 3D Medical BioPrinting Technology Reporting by Irina Robu, PhD – a forthcoming Article in “Medical 3D BioPrinting – The Revolution in Medicine, Technologies for Patient-centered Medicine: From R&D in Biologics to New Medical Devices”

Curator: Aviva Lev-Ari, PhD, RN

• Volume Four: Medical 3D BioPrinting – The Revolution in Medicine

Technologies for Patient-centered Medicine: From R&D in Biologics to New Medical Devices

 

&

• Subsidiary 5: Pharmaceutical R&D: Drug Discovery and Drug-Devices Development

Line-of-Business #7:

• Drug Discovery with 3D BioPrinting

Team developing new mechanism of action for Therapeutics and Diagnostics for Early Detection of Pancreatic Cancer

 

Line-of-Business #8:

• Drug Delivery System – One solution for many agents for many indications

Team developing solutions with Nanoparticles and with Exosomes 

We are in Business Financial Transactions (No Securities Traded)

 

• Subsidiary 2: Funding Early Stage Businesses, IP Licensing and Business Partnerships:

Line-of-Business #9:

Early Stage Venture Funding

MEDICAL DEVICES

Pharmaceutical Informational PLATFORMS

INVENTIONS IN BIOLOGICS

Representation of 13 ventures for the purpose of prospecting for funding. Seeking business partner to developing FUNDING of the following Ventures, if interested to further explore jointly, please e-mail me:

avivalev-ari@alum.berkeley.edu

 

• LPBI Group’s Portfolio of Clients include the following:

 

1. Woodland Pharmaceutical

https://gust.com/companies/woodland_pharmaceuticals

 

2. BioTerm Pharmaceuticals

http://www.bio-term.com/

 

3. Akshaya Bio Inc. – Portfolio of 28 Patents in vaccine – viral infection

http://www.akshayabio.com/

 

4. com

http://www.valvecure.com/Home.html

 

5. Alpha Sensors, Inc.

http://alphaszenszor.com/

 

6. AlphaIP, Inc.

http://www.alphaip.net/

 

7. SBH Sciences, Inc

http://www.sbhsciences.com/

 

8. Telerescue

http://www.telerescue.co.il/

 

9. New Medicine, Inc.

http://www.newmedinc.com/

 

10. LPBI Group – Aviva Lev-Ari, PhD, RN – Founder

https://pharmaceuticalintelligence.com/gama-delta-epsilon-gde-is-a-global-holding-company-absorbing-lpbi/

 

10a. DrugDiscovery @LPBI Group – Aviva Lev-Ari, PhD, RN – Co–Founder and Raphael Nir, PhD – Co–Founder

https://pharmaceuticalintelligence.com/drugdiscovery-lpbi-group/

 

11. Portfolio of Patents of S.Y. in Anti-Inflammatory, A Macro Molecule of a Multifunctional NSAID – Portfolio of 13 US Patents

Multi-Functional Anti-Inflammatory Drugs (MFAIDs): Small Molecule Invention of Dr. Saul Yedgar, HUJI and Yissum

 

12. Portfolio of Patents under management of Y. M.

 

13. Vyriad – Oncolytic Virotherapy for the Treatment of Cancer
    Vyriad – http://www.vyriad.com/

 

 

12/19/2016

We Celebrate 5,000 Scientific Articles @pharmaceuticalintelligence.com – 2016 was a GREAT Year !!!!!

https://pharmaceuticalintelligence.com/2016/12/19/we-celebrate-5000-scientific-articles-pharmaceuticalintelligence-com-2016-was-a-great-year/

12/15/2016

Super RECORD of REAL TIME Coverage of Biotech and Medicine Conferences by LPBI Group in 2016

Curator: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2016/12/14/super-record-of-real-time-coverage-of-biotech-and-medicine-conferences-by-lpbi-group-in-2016/

 

2017 World Medical Innovation Forum: Cardiovascular, May 1-3, 2017, Partners HealthCare, Boston, at the Westin Hotel, Boston

 

Reporter: Aviva Lev-Ari, PhD, RN

 

ANNOUNCEMENT

Leaders in Pharmaceutical Business Intelligence (LPBI) Group will cover the event in REAL TIME

Aviva Lev-Ari, PhD, RN will be streaming live from the floor of the Westin Hotel in Boston on May 1-3, 2017

@pharma_BI

@AVIVA1950

 

9/22/2016

Updated Business Synopsis

In 4/2012, Aviva Lev-Ari, PhD, RN has launched LPBI Group. She is an Executive-Entrepreneur with high energy and passion. Followed by 6200 Biotech professionals on LinkedIn, Group Manager of three Groups on LinkedIn in (1) Pharmaceutical Intelligence, (2) Cardiovascular Disease and (3) Innovations in Israel. Her business acumen is at the intersection of (a) electronic Scientific Media, (b) Drug Discovery and (c) Venture Funding.

LPBI Group is an early stage start up in three domains:

(1) Knowledge-based Informational Services

Open Access OnLine Scientific Journal The Site Statistics on 9/14/2016: (1,053,618 e-Readers, 2,142 Subscribers, 4,892 Scientific Articles, ~8000 Comments by Scientists)

BioMed e-Series, Five Series in Medicine, 8 e-Books on Amazon.com, 4 e-Books in 2016 and 3 e-Books in 2017

Real Time Press Coverage of BioTech Global Premier Conferences, Portfolio of ~30 events have been covered in the last 3 years. In 2016, Dr. Lev-Ari has launched an

Audio-Podcast Series in Medicine, 5 tracks.

Representation of US Patent Holders for Commercialization, Licensing and Partnerships

(2) Dr. Lev-Ari guides a Team of Scientists in Drug Discovery & Drug Delivery Research

• Drug Discovery with 3D BioPrinting
• Drug Delivery System – One solution for many agents for many indications

(3) As a Key Opinion Leader (KOL) Dr. Lev-Ari and her Team are involved in Business Financial Transactions (No Securities Traded)

·       Funding Early Stage Ventures and Businesses, IP Licensing and Business Partnerships for MEDICAL DEVICES, Pharmaceutical Informational PLATFORMS and INVENTIONS IN BIOLOGICS.

 

 

9/1/2016

• Oncolytic Virus Immunotherapy Unlocking Oncolytic Virotherapies: From Science to Commercialization CHI’S 4TH ANNUAL IMMUNO-ONCOLOGY SUMMIT – AUGUST 29-30, 2016 | Marriott Long Wharf Hotel – Boston, MAhttps://pharmaceuticalintelligence.com/2016/07/15/agenda-for-oncolytic-virus-immunotherapy-unlocking-oncolytic-virotherapies-from-science-to-commercialization-chis-4th-annual-immuno-oncology-summit-august-29-30-2016-marriott-lo/

Real Time Coverage and eProceedings of Presentations on August 29 and August 30, 2016 CHI’s 4th IMMUNO-ONCOLOGY SUMMIT – Oncolytic Virus Immunotherapy Track

https://pharmaceuticalintelligence.com/2016/09/01/real-time-coverage-and-eproceedings-of-presentations-on-august-29-and-august-30-2016-chis-4th-immuno-oncology-summit-oncolytic-virus-immunotherapy-track/

LIVE Tweets via @pharma_BI and by @AVIVA1950 for August 29 and August 30, 2016 of CHI’s 4th IMMUNO-ONCOLOGY SUMMIT – Oncolytic Virus Immunotherapy Track, Marriott Long Wharf Hotel – Boston

https://pharmaceuticalintelligence.com/2016/09/01/live-tweets-via-pharma_bi-and-by-aviva1950-for-august-29-and-august-30-2016-of-chis-4th-immuno-oncology-summit-oncolytic-virus-immunotherapy-track-marriott-long-wharf-hotel/

7/14/2016

ANNOUNCEMENT

Leaders in Pharmaceutical Business intelligence will cover in Real Time using Social Media

The CHI’S 4^TH ANNUAL IMMUNO-ONCOLOGY SUMMIT – Personalized Immunotherapy

Personalized Oncology in the Genomic Era: Expanding the Druggable Space

http://www.immuno-oncologysummit.com/

Aviva Lev-Ari, PhD, RN

will be streaming LIVE from the Marriott Long Wharf Hotel in Boston, MA

https://pharmaceuticalintelligence.com/2016/07/14/personalized-immunotherapy-the-immuno-oncology-summit-august-30-31-2016-boston-ma/

6/8/2016

1. We added a Potential Scientific Partner to DrugDiscovery @LPBI Group
2. We added a New Candiddate for Funding Biologics Translational Research @LPBI Group

• Akshaya Bio, Inc.: Chimigen® Technology – Rajan George, PhD, President and CSO

Re-educating Immune System to Fight Diseases

www.akshayabio.com

• Unique technology platform
• Improved antigen presentation
  • –  “Mimics Body’s Own Natural Immune Response Process”
  • –  No adjuvant, avoids adverse reactions
• Rich product pipeline

– HBV, HCV, HIV, Cancer, Malaria, Biodefense, Influenza, TB, Ebola

6/2/2016

Electronic Proceedings for 10th US-India BioPharma & Healthcare Summit, June 2, 2016, Marriott Cambridge, MA

Curator: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2016/06/04/electronic-proceedings-for-10th-us-india-biopharma-healthcare-summit-june-2-2016-marriott-cambridge-ma/

 

LIVE Tweets via @pharma_BI and by @AVIVA1950 for 10th US-India BioPharma & Healthcare Summit, June 2, 2016, Marriott Cambridge, MA

Curator: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2016/06/04/live-tweets-via-pharma_bi-and-by-aviva1950-for-10th-us-india-biopharma-healthcare-summit-june-2-2016-marriott-cambridge-ma/

 

5/24/2017

10th US-India BioPharma & Healthcare Summit, Thursday, June 2, 2016, Marriott Cambridge, MA

https://pharmaceuticalintelligence.com/2016/05/24/10th-us-india-biopharma-healthcare-summit-thursday-june-2-2016-marriott-cambridge-ma/

5/17/2016

LPBI Group will cover in Real Time The 16th annual EmTech MIT – A Place of Inspiration, October 18-20, 2016, Cambridge, MA

https://pharmaceuticalintelligence.com/2016/05/17/the-16th-annual-emtech-mit-a-place-of-inspiration-october-18-20-2016-cambridge-ma/

5/17/2016

We have progress made

1. We diversified – now we handle 9 types of businesses

https://pharmaceuticalintelligence.com/drugdiscovery-lpbi-group/

2.  We are Co-Partnering with CHI, the largest Life Sciences Conferences organizers in the US on the following event:

https://pharmaceuticalintelligence.com/2016/05/13/announcement-from-lpbi-group-key-code-lpbi16-for-exclusive-discount-to-attend-bostons-discovery-on-target-september-2016/

3. Commercialization of US Patents

• I was awarded representation from YISSUM, HUJI’s Technology Transfer Office,  Prof. Saul Yedgar’s  –13 US patents
• I will represent 26 +2 Patents in Immunology by Dr. R. George
• I continue with new sources for funding for Early stage.

4. We branched into Drug Discovery 

https://pharmaceuticalintelligence.com/drugdiscovery-lpbi-group/

5. We published EIGHT e-Books in Medicine on Amazon.com

WE ARE ON AMAZON.COM

http://www.amazon.com/dp/B00DINFFYC

http://www.amazon.com/dp/B018Q5MCN8

http://www.amazon.com/dp/B018PNHJ84

http://www.amazon.com/dp/B018DHBUO6

http://www.amazon.com/dp/B013RVYR2K

http://www.amazon.com/dp/B012BB0ZF0

http://www.amazon.com/dp/B019UM909A

http://www.amazon.com/dp/B019VH97LU

6. We are working on an e-Book on 3D BioPrinting

https://pharmaceuticalintelligence.com/biomed-e-books/series-e-titles-in-the-strategic-plan-for-2014-1015/volume-four-medical-3d-bioprinting-the-revolution-in-medicine/

7. We are working on an e-Book on Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS & BioInformatics, Simulations and the Genome Ontology (Work-in-Progress)

Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS & BioInformatics, Simulations and the Genome Ontology

8. We are working on an e-Book on The VOICES of Patients, HealthCare Providers, Care Givers and Families: Personal Experience with Critical Care and Invasive Medical Procedures (Work-in-Progress)

Volume One: The VOICES of Patients, HealthCare Providers, Care Givers and Families: Personal Experience with Critical Care and Invasive Medical Procedures

 

4/28/2016

we plan to attend

From: “W. Eric L. Grimson PhD ’80, MIT Chancellor for Academic Advancement” <techbfast@mit.edu>

Date: Thursday, April 28, 2016 at 10:52 AM

To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: Technology Breakfast, June 2

Dear Aviva,

Please join me on Thursday, June 2, for our next Technology Breakfast. It will be held in the new Samberg Conference Center in the Morris and Sophie Chang Building (E52). The MIT Technology Breakfast series brings together alumni, faculty, and friends to hear distinguished members of the MIT community speak on topics at the forefront of today’s technology.

Our featured company will be Luminoso. Founded in 2010 and headquartered in Cambridge, Massachusetts, Luminoso is an artificial intelligence-based software company that applies natural language processing and machine learning technologies to data analytics. Cofounder and chief executive officer Catherine Havasi ’03, MNG ’04 and cofounder and chief technology officer Jason Alonso ’04, SM ’08 will join us.

Coffee and buffet breakfast will be available at 7:00 am. The program will begin at 8:00 am and conclude at 9:00 am. Upon request, parking will be reserved for you at the MIT Hayward Lot. To confirm your attendance, please respond by Thursday, May 26, via reply e-mail. If you have questions, feel free to contact Brenda Richard at 617.253.0022 or brendar@mit.edu.

I look forward to seeing you on June 2.

Sincerely,

W. Eric L. Grimson

Chancellor for Academic Advancement

————————————————–

EVENT DETAILS

MIT Technology Breakfast

Thursday, June 2, 2016

Samberg Conference Center, 7th floor

The Morris and Sophie Chang Building (E52)

50 Memorial Drive

Cambridge, Massachusetts

7:00 am Coffee and buffet breakfast available

8:00 am Program begins

9:00 am Program concludes

Please respond by May 26 and include your NAME, TITLE, and COMPANY as you would like this information to appear on your name badge and in the program brochure.

Kindly indicate whether you will require parking.

For the location of the MIT Samberg Conference Center, please refer to: http://whereis.mit.edu/?go=E52

For the location of the MIT Hayward Lot, please refer to: http://whereis.mit.edu/map-jpg?selection=P5&Parking=go

————————————————–

About Catherine Havasi and Jason Alonso

Catherine Havasi is a cofounder and the chief executive officer of Luminoso. Luminoso is based on nearly a decade of research at the MIT Media Lab on how natural language processing and machine learning could be applied to text analytics. Havasi also directs the Open Mind Common Sense Project, one of the largest common sense knowledge bases in the world, which she cofounded with Marvin Minsky and Push Singh in 1999. She earned an SB and an SM in electrical engineering and computer science from MIT, and a PhD in computer science from Brandeis University.

Jason Alonso is a cofounder and the chief technology officer of Luminoso. He joined the Open Mind Common Sense Project in 2006. In 2007, he cofounded and was the first CFO of Learning Unlimited, an education nonprofit with roots in the MIT Educational Studies Program. Alonso earned an SB in electrical engineering and computer science and an SM in media arts and sciences from MIT.

 

4/12/2016

1.  Announcing David Orchard-Webb, PhD joined LPBI Group as Expert, Author, Writer with expertise in Cancer Biology and “DrugDiscovery @LPBI Group” as Scientist II working on Anti-Cancer Drug Discovery: TCRL
2.  CHI proposal to co-Partner the CRISPR Conference in Boston,September 19-22,2016

https://pharmaceuticalintelligence.com/2016/04/06/understanding-crispr-mechanisms-and-applications-chi-september-19-22-2016-westin-boston-waterfront-boston/

 

4/5/2016

1.  Agreement with Yissum regarding 13 Patents of SY is on its way
2.  Mr. A.D. of Los Angeles will meet with Zur Technologies, CEO and with BioTerm Pharmaceutical regarding Funding Opportunities

 

4/4/2016

“DrugDiscovery @LPBI Group” is a Start Up in Health/Life Sciences in MA

VISIT our Web site

https://pharmaceuticalintelligence.com/drugdiscovery-lpbi-group/

The Team

Team Profile: DrugDiscovery @LPBI Group – A BioTech Start Up submitted for Funding Competition to MassChallenge Boston 2016 Accelerator

 

We are Applicants for MassChallenge Boston 2016 Accelerator

https://accelerate.masschallenge.org/startup/11021/team/

 

4/3/2016

• Announcing Contributing Editor and Author
  

  Gail S. Thornton, PhD(c)

  Series E Volume One – Sourcer for Patient Accounting on Voicing Post Invasive Interventions

4/3/2016

• I will announce Replacement to Adam Sonnenberg for the role of:

Research Associate on BioMed e-Series

– Content Digitization, e-Format Conversion and Complex Proof Reading

Debashree Chakrabarti, MSc (5/2016), Research Associate for Enterprise Technologies: E-Scientific Publishing and Drug Discovery

4/3/2016

From: MassChallenge <contact@masschallenge.org>

Reply-To: <contact@masschallenge.org>

Date: Saturday, April 2, 2016 at 3:17 PM

To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: MC Update – Applications Close 

Click to Browse the 2016 Startup Applicants

We are DrugDiscovery@LPBI Group – Boston 2016 – Health/Life Sciences

– Three Indications:

• Diabetes – A Combination Drug Therapy to induce Insulin Production by Pancreatic Beta Cells (PPAR-gamma, Leptin, ..)
• Inflammatory Disorders: Inflammatory Bowel Diseases (IBD) – Crohn’s and Ulcerative Colitis (UC) and Others
• Anti-Cancer Drug Discovery @ LPBI Group’s Research Biotech Businesses

 

3/28/2016

From: MassChallenge <apply@masschallenge.org>

Date: Monday, March 28, 2016 at 1:11 PM

To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Cc: MassChallenge <apply@masschallenge.org>

Subject: Your MassChallenge 2016 Jun-Oct Program Cycle Application for DrugDiscovery@LPBI Group has been Submitted

Hi Aviva,

Thank you for submitting your application for MassChallenge Boston 2016 Accelerator for your startup, DrugDiscovery@LPBI Group. It has been received and will be reviewed by MassChallenge judges.

Best,

The MassChallenge Team

3/24/2016

You Need a New Professional Opportunity or a Business to Manage? an Affiliation? a Bigger Challenge?

• we have a ROLE for you

——>>>>>>   This is a PREP for Your 2016 Professional Renewal

Author: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2016/03/14/you-need-a-new-job-an-affiliation-a-bigger-challenge-this-is-a-prep-for-your-2016-professional-renewal/

3/23/2016

From: “Gregory Piatetsky, KDnuggets” <editor1@kdnuggets.com>

Date: Wednesday, March 23, 2016 at 1:56 PM

To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: Re: Please run for me this to your LISTSERVE – I can promote any event of yours in reciprocity

Aviva,

I have posted your job ad on www.kdnuggets.com/news

and www.kdnuggets.com/jobs  pages.

Please check

http://www.kdnuggets.com/jobs/16/03-23-pharmaceuticalintelligence-professional-opportunity-pharma-bi-b.html

Will also share it on KDnuggets Twitter, Facebook page, LinkedIn group, Google+, and RSS , and include it in the next issue (Mar 30) of KDnuggets News email newsletter.

Gregory Piatetsky

President, KDnuggets

 

3/17/2016

BILL ZURN 

Cardiovascular Medical Devices Inventor:

William Harrison Zurn

UPDATED on 3/17/2016

Bill Zurn is Founder and Chairman of the Board “Vascular Devices” – LLC, a start-up company chartered to develop his patented, untethered human vessel catheter.

This catheter is the world’s first untethered catheter, a fifth generation device that produces a burst of laser energy to vaporize vessel blockages.

3/2/2016

GDE Enterprises changed name to LPBI Group

2/25/2016

Published on 2/25/2016:

• PROTOCOL for GDE’s Recruiting Strategy for R&D Scientists I,II,III and R&D Project Managers for Drug Discovery: Three Indications Considered
• PROTOCOL for Drug Screening of 3rd Party Intellectual Property Presented for Funding Representation

2/23/2016

• Discussed R&D in Anti-Cancer Drug development with TB & ZR on 2/13/2016
• Discussed R&D in Anti-Cancer Drug development with DOW & RT on 2/24/2016
• Nominated Dr. Larry H. Bernstein to PMC 2016 Award on 2/18/2016
• Touched basis with our Financial Placement Agency in NYC 2/19/2016
• Secured Alpha Szenszors, Inc. Presentation for our Financial Placement Agency in NYC on 2/22/2016
• In Discussions with a Medical Devices BD
• Invited Dr. Singer for 2 days in Boston for training on Demos of BioMed Series to Dean’s of Medical Schools
• Dr. Cohn’s Paper awaits posting in the Journal
• Mr. Zurn’s Presentation, 2/18 awaits Aviva’s editing, posting in the Journal and placement in Series E, Volume 4.
• Dr. Codrington will pursue her own venture, EAW’s Status changed to Inactive, 2/19
• Dr. Cohn – on leave of absence, EAW’s Status changed to Inactive, 2/19

 

 

 

2/18/2016

Aviva nominate Larry H. Bernstein, MD, FCAP for 12th Annual Award for Leadership in Personalized Medicine

Letter of nomination for 12th Annual Award for Leadership in Personalized Medicine

Larry H. Bernstein, MD , FCAP 

Dr. Bernstein had advanced the Personalized Medicine Paradigm in a pursuit of over 40 years of a career in Medicine. 

In his own words:

My Life in Medicine: Larry H. Bernstein, M.D.

www.linkedin.com/pub/larry-h-bernstein/a/599/50

I retired from a five year position as Chief of the Division of Clinical Pathology (Laboratory Medicine) at  New York Methodist Hospital-Weill Cornell Affiliate, Park Slope, Brooklyn in 2008 followed by an interim consultancy at Norwalk Hospital in 2010.  I then became engaged with a medical informatics project called “Second Opinion” with Gil David and Ronald Coifman, Emeritus Professor and Chairman of the Department of Mathematics in the Program in Applied Mathematics at Yale.  I went to Prof. Coifman with a large database of 30,000 hemograms that are the most commonly ordered test in medicine because of the elucidation of red cell, white cell and platelet populations in the blood.  The problem boiled down to a level of noise that exists in such data, and developing a primary evidence-based classification that technology did not support until the first decade of the 21^stcentury. READ MORE

https://pharmaceuticalintelligence.com/contributors-biographies/members-of-the-board/larry-bernstein/

In my own words: 

The Young Surgeon and The Retired Pathologist: On Science, Medicine and HealthCare Policy – The Best Writers Among the WRITERS

Curator: Aviva Lev-Ari, PhD, RN

Of all the readings and reviews I completed to date, my appreciation got bonded to two Science and Medicine writers:

• a Young Surgeon, Atul Gawande, MD, MPH

and

• a Retired Pathologist, Pathophysiologist, Histologist, Bacteriologist, Chemical Geneticist, BioChemist, Enzymologist, Molecular Biologist, Mathematical Statistician and more, Larry H Bernstein, MD, FCAP

I am inviting the e-Readers to join me on a language immersion during a LITERARY TOUR in Science, Medicine and HealthCare Policy. 

https://pharmaceuticalintelligence.com/2013/12/10/the-young-surgeon-and-the-retired-pathologist-on-science-medicine-and-healthcare-policy-best-writers-among-the-writers/

• Dr. Bernstein has expressed his views on Personalized Medicine in a series of articles on Predicted Cost of Care and the Affordable Care Act, Impact of 2013 HealthCare Reform in the US & Patient Protection and Affordable Care Act 

https://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/volume-two-cardiovascular-original-research-cases-in-methodology-design-for-content-co-curation/

• His views of advocacy for Personalized Medicine are expressed in EIGHT Books and another two in the Printing Process for 2016 publication, as follows:

2013 e-Book on Amazon.com

• Perspectives on Nitric Oxide in Disease Mechanisms, on Amazon since 6/2/12013

http://www.amazon.com/dp/B00DINFFYC

2015 e-Book on Amazon.com

• Metabolic Genomics and Pharmaceutics, on Amazon since 7/21/2015

http://www.amazon.com/dp/B012BB0ZF0

• Cancer Biology & Genomics for Disease Diagnosis, on Amazon since 8/11/2015

http://www.amazon.com/dp/B013RVYR2K

• Genomics Orientations for Personalized Medicine, on Amazon since 11/23/2015

http://www.amazon.com/dp/B018DHBUO6

• Milestones in Physiology: Discoveries in Medicine, Genomics and Therapeutics, on Amazon.com since 12/27/2015

http://www.amazon.com/dp/B019VH97LU

• Cardiovascular, Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation, on Amazon since 11/30/2015

http://www.amazon.com/dp/B018Q5MCN8

• Cardiovascular Diseases, Volume Three: Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics, on Amazon since 11/29/2015

http://www.amazon.com/dp/B018PNHJ84

• Cardiovascular Diseases, Volume Four: Regenerative and Translational Medicine: The Therapeutics Promise for Cardiovascular Diseases, on Amazon since 12/26/2015

http://www.amazon.com/dp/B019UM909A

Completed Volumes in PRINTING Process for 2016 Publication

Series C: e-Books on Cancer & Oncology

Volume 2: Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery

Authors, Curators and Editors:

Larry H Bernstein, MD, FCAP and Stephen J Williams, PhD

2016

https://pharmaceuticalintelligence.com/biomed-e-books/series-c-e-books-on-cancer-oncology/volume-2-immunotherapy-in-oncology/

Series E: Patient-Centered Medicine

Volume 2: Medical Scientific Discoveries for the 21st Century & Interviews with Scientific Leaders

Author, Curator and Editor: Larry H Bernstein, MD, FCAP

2016

https://pharmaceuticalintelligence.com/biomed-e-books/series-e-titles-in-the-strategic-plan-for-2014-1015/2014-interviews-with-scientific-leaders/

Nominator for the 12th Annual Award for Leadership in Personalized Medicine:

Aviva Lev-Ari, PhD, RN

Director & Founder

Leaders in Pharmaceutical Business Intelligence, Boston

Editor-in-Chief

http://pharmaceuticalintelligence.com

@pharma_BI

Co-Founder, GDE Enterprises, 

Boston, USA  and Lausanne, Switzerland

e-Mail: avivalev-ari@alum.berkeley.edu

SkypeID: HarpPlayer83

2/8/2016

Submission for Category: Book

Nomination of e-Book, Series A: Cardiovascular Diseases, Volume 2, Cases in Development of Scientific Curation Methodology

2016 Communication Awards Nomination Form Result #9143807

The National Academies of Sciences, Engineering, and Medicine

2016 Communication Awards for Excellence in Reporting and Communicating Science, Medicine and Engineering

Nomination Confirmation 

 

Thank you for submitting a nomination for the 2016 National Academies Communication Awards. Below please find the supporting materials necessary for your nomination category, as well as the address to which they should be sent.

Please select the category of your nomination: *	Book
Book Title: *	Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation
Publisher(s): *	Amazon Kindle Direct
Publication Date: (Please select one): *	November 2015
Book Entry Summary (Please limit to 100 words): *	The explosion of scientific information has created difficulties tying together disparate discoveries, ideas, and potential applications. Pharmaceutical Business Intelligence is developing an innovative methodology for Global access to Biomedical knowledge rather than traditional search. To attain this complex goal they disseminate ORIGINAL Research via Content Curation by experts using critical thinking process & interpretation over open access networks, offering better organization and visibility of critical information useful for innovations in academic, clinical, and industrial research. Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation at http://www.amazon.com/dp/B018Q5MCN8 is nominated as an example of this methodology.
Are you nominating an individual or team (up to four individuals)? *	Team
Is this a self- or third-party nomination? *	Third-Party Nomination: I am nominating someone other than myself.
First Name *	Larry H
Last Name *	Bernstein, MD, FCAP
Title *	Chief Scientific Officer
Organization *	Leaders in Pharmaceutical Business Intelligence
Street Address	54 FIRETHORN LANE
City	NORTHAMPTON
State	MA
Postal Code	01060
Country	USA
E-Mail Address *	larry.bernstein@gmail.com
Phone Number *	4137278523
URL	http://pharmaceuticalintelligence.com
First Name	AVIVA
Last Name	Lev-Ari, PhD, RN
Organization	Leaders in Pharmaceutical Business Intelligence
E-Mail Address	avivalev-ari@alum.berkeley.edu
First Name	Justin D.
Last Name	Pearlman, MD, PhD, FACC
Organization	Leaders in Pharmaceutical Business Intelligence
E-Mail Address	jdmdphd@gmail.com
First Name *	Stephen J.
Last Name *	Williams, PhD
Title *	Editor
Organization *	Leaders in Pharmaceutical Business Intelligence
Street Address	7373 Ridge Avenue
Apt/Suite/Office	116
City	Philadelphia
State	PA
Postal Code	19128
Country	USA
E-Mail Address *	sjwilliamspa@comcast.net
Phone Number *	2154870259
URL	http://pharmaceuticalintelligence.com

2/2/2016

Nominations for 2016 National Academies Communication Awards For Excellence in Reporting and Communicating Science, Engineering, and Medicine, Keck Futures Initiative

Editor-in-Chief: Aviva Lev-Ari, PhD, RN

• LPBI’s BioMed e-Series, 15 e-Books Titles in Medicine and Life Sciences on Amazon.com
• LPBI’s Open Access Online Scientific Journal, http://pharmaceuticalintelligence.com
• LBPI’s BioMed e-Series Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation as an ezample of the innovative methodology of curation in Medicine and Science

https://pharmaceuticalintelligence.com/2016/02/02/nominations-for-2016-national-academies-communication-awards-for-excellence-in-reporting-and-communicating-sciences-engineering-and-medicine/

1/27/2016

#1    Launching LPBI’s, Fourth Line of Business D. 

FIVE Podcast – Audio Series in BioMed in the following Domains of Medicine and Life Sciences:

• Series #1: Dr. S. Saha – Reproductive Genomics

A Podcast – Audio Series on Reproductive Genomics, Male infertility and Research Breakthroughs in Female Genomic Endocrinology

• Series #2: Dr. SJ Williams – Genomics & Gene Therapy

A Podcast – Audio Series on Gene Editing and 3D BioPrinting

• Series #3: Dr. SJ Williams – Genomics & Cancer

A Podcast – Audio Series on Immune-Oncology Molecules in Development

• Series #4: Dr. A. Lev-Ari – the ART of e-Scientific Curation of Scientific Findings

A Podcast – Audio Series on CONTENT CREATION for Scientific Digital Media: Journal, e-Books, Biotech Conference Coverage in REAL TIME

• Series #5: Dr. I. Robu – Tissue Engineering & 3D Printing Materials

A Podcast – Audio Series on Medical 3D BioPrinting

#2    LPBI’s BioMed e-Series  was Submitted, Reference #: 9076095, on 1/27/2016 to

The Keck Futures Initiative – a program of the National Academies of Sciences, Engineering, and Medicine, with the support of the W.M. Keck Foundation – will award four $20,000 prizes in 2016 to individuals or teams (up to four individuals associated with the creation of the work being nominated) who have developed creative, original works that address issues and advances in science, engineering and/or medicine for the general public. Nominations are accepted in four categories: Book; Film/Radio/TV; Magazine/Newspaper; and Online. The winners will be honored in the Fall 2016 and are expected to attend in person.

http://keckfutures.org/awards/nominate.html

https://fs22.formsite.com/naseo-ca/2016_com_award_nom/index.html 

1/27/2016

I AM PROUD TO CONGRATULATE

• Larry H Bernstein, MD, FCAP
• Stephen J Williams, PhD
• Tilda Barliya, PhD
• Dror Nir, PhD

They constitute the TEAM that I nominated for The National Academies 2016 Communication Awards, Keck Futures Initiative – Nomination

• Category: Online
• Subject for Nomination: BioMed e-Series published in 2015 by Leaders in Pharmaceutical Business Intelligence

BioMed e-Series

https://pharmaceuticalintelligence.com/biomed-e-books/

• Cancer Biology & Genomics for Disease Diagnosis,
• Genomics Orientations for Personalized Medicine,
• Metabolic Genomics and Pharmaceutics,
• Milestones in Physiology: Discoveries in Medicine, Genomics and Therapeutics,
• Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics,
• Regenerative and Translational Medicine: The Therapeutics Promise for Cardiovascular Diseases

100 words

BioMed e-Series published in 2015 e-Books to popularize the Scientific findings of the frontier in Medicine and Life Sciences focusing on the top two Public HealthCare hazards: Cardiovascular Diseases and Cancer. The e-Series consists of medical interpretations of the most challenging causes of mortality and morbidities in Cancer Biology & Genomics for Disease Diagnosis, Genomics Orientations for Personalized Medicine, Metabolic Genomics and Pharmaceutics, the Milestones in Physiology: Discoveries in Medicine, Genomics and Therapeutics, the Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics. Precision Medicine as EndFragment

https://fs22.formsite.com/res/showSuccessPage?EParam=m%2FOmK8apOTBRmouoTFrqiVATUbkBsVmGEQn3K0X14DG3VhR5CvnKsC1mzhLD6ne%2BXKN%2Fe20J%2FjE%3D

1/5/2016

• Accomplishments by Subsidiary #1: Scientific Media

A.  The Journal

Our Realization              2014                2015               All Times  Total on 1/3/2016

# e-Readers                230,000                   300,000                841,700

New Articles        1,087 (+41.58%)           1,316 (+30.95%) 

Total # of Articles          2,614                          3,929                         3,937

B.   WE ARE on AMAZON.COM with EIGHT e-Books in Medicine

http://www.amazon.com/dp/B00DINFFYC

http://www.amazon.com/dp/B018Q5MCN8

http://www.amazon.com/dp/B018PNHJ84

http://www.amazon.com/dp/B018DHBUO6

http://www.amazon.com/dp/B013RVYR2K

http://www.amazon.com/dp/B012BB0ZF0

http://www.amazon.com/dp/B019UM909A

http://www.amazon.com/dp/B019VH97LU

C.  Press Coverage

The 11th Annual Personalized Medicine Conference, November 18-19, 2015, Joseph B. Martin Conference Center of the Harvard New Research Building at Harvard Medical School

The 15th Annual EmTech MIT, November 2–4, 2015, MIT Media Lab, Cambridge, MA

Explores technologies highlighted in the recent 10 Breakthrough Technologies list and celebrates the 2015 Innovators Under 35.

9/17/2015 -LIVE – Real Time Coverage of Kailath Lecture and Colloquium 2015 September 17 – 19, Stanford CA – James H. Clark Center, 318 Campus Drive West, Stanford University, CA

9/18/2015 – LIVE – Real Time Coverage of Kailath Lecture and Colloquium 2015 September 17 – 19, Stanford CA – James H. Clark Center, 318 Campus Drive West, Stanford University, CA

Cambridge HealthTech Institute’s 14th Annual Meeting BioIT World – Conference & Expo ’15, April 21 – 23, 2015 @Seaport World Trade Center, Boston, MA

MassBio Annual Meeting 2015, Cambridge, MA, Sonesta Hotel, March 26 – March 27, 2015

Silicon Valley 2015 Personalized Medicine World Conference, Mountain View, CA, January 26, 2015, 8:00AM to January 28, 2015, 3:30PM PST

Subsidiary #2: Funding Early Stage Biotech: IP by others

• Dealings with Yissum — on hold
• No Progress on other ventures, yet
• Average investment needed per venture $10Million and above

Subsidiary #3: Medical 3D BioPrinting (M3DP): Team of 15

Funding needs: $20Million

8/2015 – 12/2015 – Team accomplished a 14 Presentation Series on 3D BioPrinting for

Tissue Engineering, Gene Therapy: Stem Cells and Gene Editing and Drug dosing and printing, artificial organs, MEMS and Programmable Sensors

1/2016 – 3/2016 – Team engaged in Presentations on BioMEMS

4/2016 – 6/2016 – Team engaged in Presentations on Stem Cells

• Gerard manages VARS of BioPrinters and BioInks

Subsidiary #4: U.S. and Int’l Patents

• Funding needed to commercialize,
• Partnerships to license
• Buyers for Sales of IP of Two Team members:

(a) to “corporate accounts”

(b) to “IP and Technology Patents Fund Managers

Subsidiary #5: Joint Venture: SBH & M3DP (same Team as Subsidiary #3)

Funding needs: $10 Million

• Dr. Nir and Aviva manage creation of a pipeline of Product Concepts

@@@@@@@@@

2015

12/2/2015

 

Please write a Book Review on Amazon.com – for ONE of our e–Books in your domain of expertise in Medicine

 

The entire BioMed e-Series – Sixteen Titles, is at

https://pharmaceuticalintelligence.com/biomed-e-books/

 

Series A: e-Books on Cardiovascular Diseases

Content Consultant: Justin D Pearlman, MD, PhD, FACC

 

Volume One: Perspectives on Nitric Oxide

available on Kindle Store @ Amazon.com

http://www.amazon.com/dp/B00DINFFYC

Sr. Editor: Larry Bernstein, MD, FCAP, Editor: Aviral Vatsa, PhD and Content Consultant: Stephen J Williams, PhD

 

Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation

  available on Kindle Store @ Amazon.com 

 http://www.amazon.com/dp/B018Q5MCN8

Curators: Justin D Pearlman, MD, PhD, FACC, Larry H Bernstein, MD, FCAP, Aviva Lev-Ari, PhD, RN

 

Volume Three: Etiologies of CVD: Epigenetics, Genetics & Genomics

available on Kindle Store @ Amazon.com 

http://www.amazon.com/dp/B018PNHJ84

Curators: Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN

 

Series B: e-Books on Genomics & Medicine

Content Consultant: Larry H Bernstein, MD, FCAP

 

Volume One: Genomics and Personalized Medicine

available on Kindle Store @ Amazon.com

http://www.amazon.com/dp/B018DHBUO6

Sr. Editor: Stephen J Williams, PhD

Editors: Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN

 

Series C: e-Books on Cancer & Oncology

Content Consultant: Larry H Bernstein, MD, FCAP

 

Volume One: Cancer and Genomics

available on Kindle Store @ Amazon.com

http://www.amazon.com/dp/B013RVYR2K

Sr. Editor: Stephen J Williams, PhD, Editors: Ritu Saxena, PhD, Tilda Barliya, PhD

 

 

Series D: e-Books on BioMedicine & Immunology

Content Consultant: Larry H Bernstein, MD, FCAP

 

Volume One: Metabolic Genomics & Pharmaceutics

available on Kindle Store @ Amazon.com

http://www.amazon.com/dp/B012BB0ZF0

Author, Curator and Editor: Larry H Bernstein, MD, FCAP

 

 

11/11/2015

#1.    Investor Relations

1.1     CCP

Class Asset A: Funding Start Ups

Class Asset B: Funding with agreement in place

B.1 ValveCure

B.2 New Medicine, Inc.

B.3 SBH Sciences, Inc.

B.4 Woodland Pharmaceuticals

Class Asset C: US Patents and International Patents of Technology Transfer Office

Class Asset D: US Patents M3DP’s Medical Devices Inventors

D.1 Bill Zurn

D.2 Dr. Pearlman

1.2     Dr. Choppe

1.2.1  Class Asset D: US Patents M3DP’s Medical Devices Inventors

D.1 Bill Zurn

D.2 Dr. Pearlman

1.2.2  M3DP and SBH Sciences, Inc. –  Joint Venture: Four Projects

We are developing a Business Plan for the Joint Venture of GDE’s Subsidiary #3: M3DP with our Business Partner for this JOINT VENTURE, DBA, SBH Sciences, Inc.

We are working on Four Projects:

Project #1:

• A Drug/Device of continuous Hormone delivery Stimulant to Insulin production for Type 1 Diabetes (Patients born with deficient Pancreas Beta Cells) and DM Type 2

A Joint Venture of the following Teams:

Technology Management: Aviva Lev-Ari, PhD, RN

Business Management: Gerard Loiseau, ESQ

SBH Sciences, Inc. 

Inventor: – CEO, CSO – Dr. Rapahel Nir

and

M3DP  

Inventors: Orange – US Patents Holder; Purple – UK Patent Holder

Dr. Pearlman and Bill Zurn on MEDICAL DEVICE DESIGNS

Dr. Codrington and Dr. Dragoi on Nanoparticals and magnetic fields

Dr. Codrington and Dr. Goswami on Molecular Cell Differentiation and Stem Cell Implantation

Dr. Williams, Dr. Tilda, Dr. Irina, Dr. Cohn – on biochemistry, biomechanics, pharmacodynamics and pharmacokinetics of the Drug 3D BioPrinting

Project #2:

• DIAGNOSTICS KIT for Skin Cancer using Nanotechnology

M3DP – Dr. Rosalind Codrington, Oxford, UK, Holder of two Patents issued in the UK

Project #3:

Protected: Invention: Stop MI © JDPearlman 2015

Inventor: Dr. Pearlman, US Patents Holder

Project #4:

Protected: INVENTION: 3D Reparative Transforming BioStent – Concept Description

Inventor: Dr. Pearlman, US Patents Holder

This page has the following sub pages.

• Scientific Media
• M3DP
• US Patents: Commercialization, Licensing or Sales Outright to Technology IP & Patents Funds
• Deals, Funding and Partnerships